Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,Cytoplasmic Ribosomal Proteins WP477,0.6275518588237121,2.8044644279591364,0.0,0.0,0.0,63/89,28.82%,RPS20;RPL7;RPL19;RPS8;RPS5;RPL8;RPS3;RPL4;RPS3A;RPL17;RPS23;RPS6KB1;RPL41;RPS21;RPS18;RPL30;RPL3;RPL6;RPS4X;RPL18;RPL18A;RPL10;RPS19;RPS6KA3;RPS28;RPL32;FAU;RPS13;RPS27A;RPL37;RPL5;RPLP0;RPLP1;RPL28;RPS2;RPL24;RPS17;RPS24;RPS6;RPL13;RPS11;RPL12;RPL37A;RPL10A;RPL11;RPL13A;RPL23;RPL35;RPL34;RPS16;RPL36;RPL29;RPL26;RPL31;RPL22;RPLP2;RPL23A;RPS6KA1;RPL38;RPL15;RPL27A;RPS25;RPL35A
prerank,Focal Adhesion WP306,0.4887971563725857,2.3183829479753375,0.0,0.0,0.0,66/198,25.16%,ITGA3;VCL;LAMA5;PAK2;AKT3;FLNA;LAMB1;SHC3;VEGFA;PPP1R12C;PPP1CA;ACTG1;ROCK1;ACTN4;FLNB;MAPK1;MET;PTK6;MYL12B;DIAPH1;SPP1;PPP1R12A;MAPK3;BIRC2;FLNC;CDC42;PAK1;THBS1;GSK3B;PRKCA;AKT1;TNK2;BIRC3;RAP1B;RAC1;EGFR;PIK3CB;PRKCG;CTNNB1;RAP1A;PIK3CA;ACTB;LAMC2;LAMB2;COL6A2;ARHGAP35;GRB2;PXN;VEGFC;MAPK8;IGF1R;CAV1;MYL12A;BAD;CRK;SHC1;MYL5;SOS1;AKT2;CAPN2;PIK3R3;LAMA4;FN1;ITGB4;CCND1;ROCK2
prerank,G Protein Signaling Pathways WP35,0.5380326514771934,2.2216027794979785,0.0,0.0,0.0,29/93,23.75%,AKAP11;PRKCI;GNA12;GNB1;GNAS;PRKAR1B;GNG5;PRKACB;SLC9A1;PRKAR1A;PRKCA;GNB5;GNAI2;PRKCZ;AKAP2;KRAS;CALM2;ADCY6;PRKCG;PRKAR2A;PRKACA;NRAS;CALM1;GNG12;GNA13;ADCY7;AKAP12;GNB2;PRKCH
prerank,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.6579881089038633,2.200154834803702,0.0,0.0,0.0,14/37,22.16%,SMAD3;WASL;AKT1S1;MTOR;RICTOR;RPS6KB1;GSK3B;AKT1;RPTOR;PRKAB1;TNFRSF1A;MLST8;IGF1R;SMAD2
prerank,Calcium Regulation in the Cardiac Cell WP536,0.5200863450939606,2.163146543976542,0.0,0.0,0.0,32/150,23.75%,GJC1;GNB1;YWHAZ;GNAS;PRKAR1B;GNG5;PRKACB;ITPR3;YWHAG;ATP2B1;PRKAR1A;PRKCA;GNB5;GNAI2;PRKCZ;CALM2;ADCY6;PRKCG;PRKAR2A;FKBP1A;PRKACA;CALM1;YWHAB;CALM3;GNG12;GJB5;ADCY7;YWHAE;GJB3;GNB2;SFN;PRKCH
prerank,Head and Neck Squamous Cell Carcinoma WP4674,0.5233374857753706,2.142996046095118,0.0,0.0,0.0,32/73,25.41%,CDK6;AKT3;VEGFA;TP53;NOTCH2;MTOR;TGFBR2;PRKAA1;RICTOR;FAT1;BIRC2;RB1;AKT1;KEAP1;RPTOR;EGFR;KRAS;CDKN2A;PIK3CB;CTNNB1;RPS6;PIK3CA;FKBP1A;NRAS;CUL3;MLST8;IGF1R;CDKN1A;AKT2;RHEB;CCND1;NFKB2
prerank,Pathways Regulating Hippo Signaling WP4540,0.5073302640298193,2.1261755199173464,0.0,0.002222802246377422,0.01,27/98,23.75%,SMAD3;PRKCI;MTOR;MET;GNAS;PRKAR1B;PRKAA1;PRKACB;TEAD1;CDC42;PRKAR1A;PRKCA;GNAI2;PRKAB1;RAC1;EGFR;PRKCZ;PRKCG;CTNNB1;PRKAR2A;PRKACA;NF2;IGF1R;STK3;SMAD2;LATS2;PRKCH
prerank,Common Pathways Underlying Drug Addiction WP2636,0.6092838151157748,2.0654983198296075,0.0,0.0019449519655802441,0.01,14/42,16.65%,PPP1CA;ACTG1;MAPK1;GNAS;PRKACB;MAPK3;PRKCA;RAP1B;CALM2;PRKCG;RAP1A;PRKACA;ACTB;CALM1
prerank,Modulators of TCR signaling and T cell activation WP5072,0.5757507631742893,2.0525640018054396,0.0,0.0034576923832537678,0.02,19/61,30.14%,RPRD1B;AGO1;CARD11;PLCG1;AKT1;ELOB;PCBP2;FIBP;DGKZ;TNFAIP3;CUL5;GNA13;GRB2;ARIH2;IKBKG;PDPK1;BCL10;TMEM222;PIK3R2
prerank,Ras signaling WP4223,0.43469251627140365,2.0380467831751887,0.0,0.0031119231449283904,0.02,47/184,23.53%,ABL2;PAK2;AKT3;SHC3;CALML5;GNB1;MAPK1;MET;PLCG1;GNG5;PRKACB;MAPK3;STK4;CDC42;BRAP;PAK1;PRKCA;AKT1;GNB5;RAP1B;RAC1;EGFR;KRAS;CALM2;RASA1;PIK3CB;PRKCG;RAP1A;PIK3CA;PRKACA;NRAS;CALM1;CALM3;GNG12;AFDN;GRB2;RALA;RRAS2;MAPK8;IGF1R;SHOC2;BAD;SHC1;GNB2;SOS1;AKT2;PIK3R3
prerank,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.488329475708754,2.0377799343440235,0.0,0.0028290210408439915,0.02,27/72,28.85%,ITGA3;VCL;LAMA5;AGRN;LIMS1;ACTN4;MYH9;CLDN1;PLCG1;FAT1;CD2AP;COL4A5;AKT1;CTNNB1;UTRN;NCK1;LAMB2;INF2;DNM1;CDKN1A;KRT8;ITGB4;PLAUR;SMARCAL1;PTK2;MYO1E;LRP5
prerank,ErbB signaling pathway WP673,0.48079545477290436,2.0263680100866965,0.0,0.0025932692874403255,0.02,39/91,27.11%,ABL2;PAK2;AKT3;SHC3;TP53;MTOR;MAPK1;CBL;PLCG1;MAPK3;RPS6KB1;PAK1;GSK3B;NRG4;PRKCA;AKT1;EGFR;KRAS;ERBB3;PIK3CB;PRKCG;MYC;PIK3CA;NCK1;NRAS;MAP2K4;GRB2;MAPK8;BAD;CRK;SHC1;CDKN1A;SOS1;AKT2;PIK3R3;CCND1;PTK2;CRKL;PDPK1
prerank,VEGFA-VEGFR2 Signaling Pathway WP3888,0.3673275656153975,2.0143233582018834,0.0,0.0023937870345603005,0.02,129/432,25.16%,ATF4;ABCF2;VCL;PRKCI;PAK2;NAP1L1;AKT1S1;PRRC2C;FSCN1;RPL7;TAOK2;RAB11A;BSG;VEGFA;SET;PPP1CA;ACTG1;PGD;PRKD2;MTOR;ROCK1;ANXA1;PRDX6;TMOD3;FLNB;MYH9;ADAM10;CAPZB;MAPK1;CBL;PLCG1;PRKAA1;RICTOR;CFL1;EZR;MAPK3;RPS6KB1;QKI;ARF4;RACK1;UBAP2L;LIMK1;SSR4;CDC42;PAK1;PTPRJ;STAT1;GSK3B;SH3BGRL3;SND1;NDRG1;RPL18A;EWSR1;CNP;PRKCA;AKT1;F3;RAP1B;EIF4G2;RAC1;EIF2A;HDAC1;TPM3;GATA2;EPHB2;MYO1C;BRD4;AP2S1;HGS;DHX36;CCDC124;RPL5;PRKCZ;AKAP2;ALDOA;MKNK1;LUC7L;RHOC;CTNNB1;PTPN14;STIP1;CLTC;GRB10;PABPC1;RPS6;RAP1A;PIK3CA;RPS11;NCK1;HSPB1;GRSF1;ENG;P4HA2;MAP2K4;IGFBP3;EIF3H;GIPC1;AFDN;GRB2;PXN;MLST8;YWHAE;SHB;RPL10A;GPC1;MAPK8;PTMA;RPL13A;FLII;CAV1;CTNND1;GLUD1;CDC42BPB;CRK;SHC1;NAPA;ITCH;RPL26;PLOD3;EIF4G1;TXNIP;CAPN2;TUBA1C;FN1;CCND1;CTNNA1;RPLP2;PLAUR;ROCK2
prerank,Neural Crest Cell Migration in Cancer WP4565,0.5958388007981641,1.9982681212597018,0.0,0.002222802246377422,0.02,11/43,16.03%,PAK2;TRIO;AKT3;ARF1;SORT1;PAK1;AKT1;RAC1;EPHB2;PIK3CB;PIK3CA
prerank,Wnt Signaling Pathway WP363,0.5559590226938012,1.9818024003269288,0.0,0.0031119231449283904,0.03,20/52,20.98%,CDK6;CSNK1E;MTOR;MAPK1;DVL3;CSNK1D;GSK3B;PRKCA;AKT1;RAC1;TCF3;PRKCG;CTNNB1;CTBP1;MYC;CSNK1A1;MAP3K7;MAPK8;RYK;DVL1
prerank,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.5276555269873063,1.9807466201602717,0.0,0.0029174279483703655,0.03,12/37,17.63%,MCL1;SLC2A1;VEGFA;TP53;SLC16A1;BNIP3L;PMAIP1;HK1;BAX;IGFBP2;PKM;IGFBP3
prerank,MAPK Signaling Pathway WP382,0.38793007688481645,1.933260094918274,0.0,0.008237443618928092,0.08,51/246,20.64%,ATF4;ELK4;PAK2;TAOK1;CDC25B;AKT3;PPP5C;FLNA;TAOK2;GNA12;TP53;FLNB;MAP3K2;MAPK1;TGFBR2;PRKACB;MAPK3;FLNC;STK4;MAP3K1;CDC42;PAK1;MKNK2;PRKCA;AKT1;CACNG6;RPS6KA3;RAP1B;RAC1;EGFR;KRAS;RASA1;MKNK1;TAB2;PRKCG;TNFRSF1A;MYC;RAP1A;PRKACA;HSPB1;NRAS;STMN1;MAP2K4;GNG12;GRB2;TRAF2;RRAS2;MAP3K7;MAPK8;LAMTOR3;STK3
prerank,Neural Crest Cell Migration during Development WP4564,0.578841020713631,1.931926337057219,0.0,0.0077798078623209765,0.08,10/40,16.03%,PAK2;TRIO;AKT3;ARF1;PAK1;AKT1;RAC1;EPHB2;PIK3CB;PIK3CA
prerank,Regulation of Microtubule Cytoskeleton WP2038,0.5284640718303167,1.9300804401493394,0.0,0.00818927143402208,0.09,17/46,17.18%,TRIO;TAOK1;PHLDB2;ROCK1;DIAPH1;LIMK1;CDC42;PAK1;AURKB;GSK3B;PRKCA;AKT1;RAC1;EPHB2;PIK3CA;PRKACA;STMN1
prerank,Fragile X Syndrome  WP4549,0.4522055084279534,1.9222783262198653,0.0,0.008557788648553074,0.1,38/121,23.82%,CLTB;MECP2;AKT1S1;PPP1CA;MTOR;MAPK1;SLC16A1;PLCG1;ABAT;CYFIP1;APP;RPS6KB1;EIF4A1;ALDH3A2;EIF4EBP2;PRKAR1A;PRKCA;AKT1;RPTOR;AP2S1;KRAS;DNM2;RAP1GAP;CDKN2A;MKNK1;PIK3CB;CLTC;AP2M1;PRKACA;DNM1;GRB2;MLST8;SHC1;SOS1;EIF4G1;RHEB;MAP1B;EEF1A1
prerank,PI3K-Akt signaling pathway WP4172,0.3832993616293949,1.9189320169717567,0.0,0.00815027490338388,0.1,67/340,25.23%,PPP2R5E;OSMR;ATF4;ITGA3;CDK6;LAMA5;MCL1;AKT3;LAMB1;VEGFA;TP53;CDK2;GNB1;PPP2R1A;MTOR;MAPK1;MET;PRKAA1;SPP1;GNG5;MAPK3;RPS6KB1;CREB3L2;THBS1;COL4A5;GSK3B;CSF1;PKN2;PRKCA;AKT1;GNB5;RPTOR;RAC1;EGFR;EIF4B;KRAS;EIF4E2;PIK3CB;HSP90B1;MYC;COL6A1;RPS6;PIK3CA;NRAS;LAMC2;GYS1;GNG12;LAMB2;COL6A2;IFNAR1;CREB3;GRB2;MLST8;VEGFC;IGF1R;BAD;CDKN1A;GNB2;SOS1;AKT2;RHEB;PIK3R3;LAMA4;FN1;ITGB4;CCND1;PPP2R5C
prerank,Non-small cell lung cancer WP4255,0.47028208008880595,1.9187088619486659,0.0,0.0077798078623209765,0.1,28/72,25.67%,CDK6;EML4;RXRA;AKT3;TP53;MAPK1;PLCG1;MAPK3;STK4;RB1;PRKCA;AKT1;BAX;EGFR;KRAS;CDKN2A;PIK3CB;PRKCG;PIK3CA;NRAS;GRB2;BAD;CDKN1A;SOS1;AKT2;PIK3R3;CCND1;GADD45A
prerank,DNA Replication WP466,-0.5173257956445481,-1.9122688492319544,0.0,0.037666027886076786,0.1,25/42,26.23%,MCM2;CDC6;MCM6;PCNA;MCM10;ORC1;GMNN;POLE;MCM3;PRIM2;POLD1;RFC5;PRIM1;CDC45;POLE2;MCM5;POLD3;ORC6;RFC2;CDC7;POLA1;ORC5;RFC3;RFC4;MCM7
prerank,Myometrial relaxation and contraction pathways WP289,0.4525068392407916,1.9102539749954104,0.0,0.008118060378074062,0.11,37/156,20.53%,ATF4;GNB1;ACTG1;YWHAZ;SP1;PLCG1;GNAS;PRKAR1B;GNG5;PRKACB;ITPR3;CALD1;YWHAG;PRKAR1A;PRKCA;GNB5;IGFBP2;GABPA;PRKCZ;CRCP;CALM2;ADCY6;PRKCG;PRKAR2A;DGKZ;PRKACA;ACTB;CALM1;YWHAB;CALM3;GNG12;IGFBP3;CREB3;ADCY7;ATF5;YWHAE;IGFBP6
prerank,Glioblastoma signaling pathways WP2261,0.45785688635947736,1.9032227840703948,0.0,0.007779807862320976,0.11,31/82,24.81%,CDK6;PIK3C2A;PRKCI;AKT3;TP53;CDK2;MAPK1;CBL;MET;PLCG1;MAPK3;RB1;PRKCA;AKT1;EGFR;PRKCZ;KRAS;CDKN2A;ERBB3;PIK3CB;PRKCG;PIK3CA;NRAS;MAP2K4;GRB2;EP300;IGF1R;CDKN1A;AKT2;PRKCH;CCND1
prerank,Chemokine signaling pathway WP3929,0.4454597153643562,1.8968762397993595,0.0,0.008091000176813815,0.12,41/164,27.03%,WASL;AKT3;SHC3;GNB1;ROCK1;MAPK1;GNG5;PRKACB;MAPK3;CDC42;PAK1;STAT1;GSK3B;AKT1;GNB5;GNAI2;RAP1B;RAC1;PRKCZ;KRAS;ADCY6;LYN;PIK3CB;RAP1A;PIK3CA;NRAS;GNG12;PRKX;GRB2;PXN;ADCY7;CRK;SHC1;GNB2;SOS1;AKT2;PIK3R3;ROCK2;PTK2;IKBKG;CRKL
prerank,G13 Signaling Pathway WP524,0.5453993654116307,1.8951410174540977,0.0,0.0077798078623209765,0.12,16/39,17.59%,WASL;SH3RF1;ROCK1;DIAPH1;CFL1;CYFIP1;RPS6KB1;LIMK1;CDC42;TNK2;RAC1;CALM2;PIK3CB;PIK3CA;CALM1;GNA13
prerank,Hepatitis C and Hepatocellular Carcinoma WP3646,0.5059830214893286,1.8886079839312142,0.0,0.008067948894258789,0.13,16/49,24.81%,SMAD3;CTTN;VEGFA;TP53;UCHL1;MAPK3;AKT1;BIRC3;RAC1;MYC;GRB2;CD44;MAPK8;CDKN1A;SOS1;CCND1
prerank,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.6240412405550833,1.8868309518459643,0.0,0.007779807862320976,0.13,9/20,18.66%,SLC2A1;VEGFA;TP53;PRKAA1;KEAP1;PRKAB1;RPS6;CUL3;PDHB
prerank,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6174061235061062,1.881386150246315,0.0,0.00858461557221625,0.15,11/30,22.16%,SMAD3;MTOR;MET;TGFBR2;AKT1;EGFR;KRAS;CTNNB1;NRAS;MFGE8;SMAD2
prerank,MET in type 1 papillary renal cell carcinoma WP4205,0.48201200156292257,1.8789302270372408,0.0,0.009335769434785172,0.16,26/59,23.53%,PAK2;AKT3;MAPK1;CBL;MET;PLCG1;MAPK3;CDC42;PAK1;AKT1;RAP1B;RAC1;KRAS;PIK3CB;RAP1A;PIK3CA;NRAS;GRB2;RPL11;MAPK8;BAD;CRK;CDKN1A;SOS1;AKT2;PIK3R3
prerank,Gastrin signaling pathway WP4659,0.41009465972994513,1.8784926853616806,0.0,0.009034615582050164,0.16,44/114,24.81%,VEGFA;PRKD2;MTOR;ROCK1;CLDN1;MAPK1;SP1;PLCG1;SLC9A1;MAPK3;BIRC2;RPS6KB1;CDC42;PAK1;GSK3B;ANXA2;PRKCA;AKT1;BIRC3;RAC1;EGFR;KRAS;CDKN2A;CTNNB1;YES1;MYC;RPS6;PIK3CA;PRKACA;GRB2;PXN;CD44;MAPK8;LAMTOR3;BAD;RHOD;CRK;SHC1;CDKN1A;SOS1;PIK3R3;PRKCH;ARHGEF28;CCND1
prerank,Hedgehog Signaling Pathway WP4249,0.5784943475553357,1.8755656407093166,0.0,0.008752283845111097,0.16,9/44,18.51%,PTCH1;CSNK1E;PRKACB;SPOPL;CSNK1D;FBXL17;PRKACA;CSNK1A1;CUL3
prerank,Synaptic Vesicle Pathway WP2267,0.619217221167737,1.8593365287477777,0.019230769230769232,0.011316084163375964,0.2,9/51,22.45%,SLC38A1;PARK7;AP2S1;DNM2;CLTC;AP2M1;DNM1;VAMP2;NAPA
prerank,Regulation of Actin Cytoskeleton WP51,0.4162843594187106,1.8546447454320492,0.0,0.012356165428392138,0.22,50/150,30.14%,VCL;PIK3C2A;PAK2;GNA12;ACTG1;ROCK1;MAPK1;DIAPH1;CFL1;PPP1R12A;EZR;SLC9A1;MAPK3;FGD1;LIMK1;CDC42;PAK1;PIK3C3;WASF2;RAC1;EGFR;NCKAP1;KRAS;PIK3CB;PIK3CA;ACTB;NRAS;MAPK6;GNG12;ENAH;GNA13;ARHGAP35;PXN;RRAS2;DIAPH3;CRK;SOS1;PIK3R3;ARPC5;FN1;MSN;ROCK2;RDX;PTK2;PIK3C2B;PIP4K2B;PIK3R4;RAC2;ACTN1;PIK3R2
prerank,"Relationship between inflammation, COX-2 and EGFR WP4483",0.6093883556412257,1.8486211186064931,0.0,0.012892253028989047,0.23,9/25,16.64%,AKT3;MAPK1;MAPK3;AKT1;EGFR;KRAS;PIK3CB;PIK3CA;NRAS
prerank,AGE/RAGE pathway WP2324,0.44305624586864906,1.8333300223612086,0.0,0.015127404176735233,0.28,15/66,13.16%,SMAD3;ROCK1;MAPK1;SP1;DIAPH1;EZR;MAPK3;CDC42;STAT1;PRKCA;AKT1;RAC1;DDOST;EGFR;PRKCZ
prerank,Melanoma WP4685,0.47053364141174325,1.831304439682917,0.0,0.0151390855699219,0.28,29/68,25.67%,CDK6;VCL;AKT3;CALML5;TP53;MAPK1;MAPK3;PAK1;RB1;AKT1;RAC1;BAX;KRAS;CDKN2A;CALM2;PIK3CB;PIK3CA;NRAS;CALM1;CALM3;GRB2;LAMTOR3;BAD;CDKN1A;SOS1;AKT2;PIK3R3;CCND1;GADD45A
prerank,Neovascularisation processes WP4331,0.5552378018509865,1.8158520906407276,0.0,0.01637854286804416,0.32,8/37,25.41%,SMAD3;MAPK1;MAPK3;AKT1;EPHB2;MAPK8;SMAD2;NFKB2
prerank,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.4661171265697507,1.8117854956179604,0.0,0.015958580230402003,0.32,24/46,26.87%,AKT3;MTOR;MAPK1;MAPK3;RPS6KB1;EIF4A1;PRKCA;AKT1;RPTOR;EIF4B;EIF4G3;PIK3CB;RPS6;PIK3CA;PRKACA;MAP2K4;MAPK8;CSNK2A1;AKT2;EIF4G1;PIK3R3;PIM1;EIF4A2;RPS6KA1
prerank,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.4536873425640689,1.810563581066987,0.0,0.015948606117758,0.33,33/84,23.53%,AKT3;SHC3;AXL;VEGFA;MTOR;MAPK1;MET;PLCG1;MAPK3;RPS6KB1;GSK3B;PRKCA;AKT1;BAX;EGFR;KRAS;EIF4E2;ERBB3;PIK3CB;PRKCG;MYC;RPS6;PIK3CA;NRAS;GAS6;GRB2;RRAS2;IGF1R;BAD;SHC1;SOS1;AKT2;PIK3R3
prerank,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.5294226794925854,1.7984968439600422,0.0,0.01973414677271662,0.37,11/37,11.98%,RBBP4;KDM1A;TP53;HDAC2;CBX5;RB1;CHD4;RBBP7;HDAC1;H3F3B;CBX1
prerank,Target Of Rapamycin (TOR) Signaling WP1471,0.4993420723154263,1.7892216577357036,0.0,0.020746154299522604,0.4,11/36,10.64%,AKT1S1;MTOR;PRKAA1;RICTOR;RPS6KB1;CDC42;PRKCA;AKT1;RPTOR;PRKAB1;RAC1
prerank,Alpha 6 Beta 4 signaling pathway WP244,0.4743465356878555,1.788238249833705,0.0,0.020625537123362587,0.4,18/33,30.53%,LAMA5;LAMB1;MTOR;MAPK1;MAPK3;PRKCA;AKT1;RAC1;LAMC2;LAMB2;GRB2;SHC1;SOS1;ITGB4;PTK2;LAMB3;PIK3R2;IRS2
prerank,Lipid Metabolism Pathway WP3965,0.5429418059633386,1.7859940282475486,0.0,0.021217657806329938,0.41,12/29,22.99%,AKT3;PRKAR1B;PRKAA1;PRKACB;PRKAR1A;AKT1;PRKAB1;PRKAR2A;PRKACA;FASN;ACLY;AKT2
prerank,Translation Factors WP107,0.4573206168342158,1.7844121884939284,0.0,0.02143769277617336,0.41,28/52,31.07%,EEF1D;EIF3CL;EEF1G;EIF2AK1;EIF4A1;EIF3B;EIF2AK2;EIF3A;EIF4EBP2;EIF3C;EIF2S3;EIF4B;EIF4G3;EIF3I;EIF6;PABPC1;EIF3E;EIF3H;EIF5;EIF4G1;EEF1A1;EIF1;EIF4A2;EIF5A;EIF2S1;ETF1;PAIP1;CLUH
prerank,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.4781297433333385,1.7810301839847416,0.0,0.02130990849244441,0.41,15/58,22.44%,SMAD3;LTBP3;SKI;TGFBR2;SPP1;MAPK3;THBS1;STAT1;TGIF1;CTNNB1;FKBP1A;ENG;EP300;SMAD2;INHBA
prerank,EGF/EGFR signaling pathway WP437,0.3660509235692405,1.7769749868587483,0.0,0.02251178445267346,0.45,58/162,27.46%,PRKCI;ELK4;NEDD4;MTOR;ROCK1;MAP3K2;MAPK1;CBL;SP1;PTK6;PLCG1;RICTOR;CFL1;RPS6KB1;MAP3K1;CDC42;PAK1;STAT1;INPPL1;PRKCA;AKT1;TNK2;RPS6KA3;RAC1;AP2S1;HGS;EGFR;PRKCZ;KRAS;RASA1;GRB10;REPS2;PXDN;RAP1A;AP2M1;NCK1;STMN1;DNM1;GRB2;RALA;MAPK8;CAV1;STAMBP;CRK;SHC1;ITCH;SOS1;NDUFA13;LIMK2;USP8;EPN1;JUND;PTK2;PTPN12;RPS6KA1;CRKL;PDPK1;PIK3C2B
prerank,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.531229404214664,1.776795367878743,0.043478260869565216,0.022042788943242762,0.45,14/30,26.57%,MTOR;RICTOR;GSK3B;AKT1;RPTOR;KRAS;PIK3CB;GRB10;PIK3CA;NRAS;BAD;RHEB;PIK3R3;ATG13
prerank,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.5244534986613972,1.7636019282901603,0.0,0.024133281532097723,0.46,17/50,23.53%,AKT3;MTOR;MAPK1;PRKAA1;MAPK3;RPS6KB1;GSK3B;AKT1;RPTOR;PRKAB1;KRAS;PIK3CB;PIK3CA;NRAS;AKT2;RHEB;PIK3R3
prerank,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.49040803926027243,1.761321593811741,0.020833333333333332,0.023650615901455768,0.46,15/62,19.56%,CARD11;CBL;PLCG1;MAPK3;PAK1;DLG1;GSK3B;AKT1;AHSA1;CALM2;PIK3CA;NCK1;CALM1;GRB2;MAP3K7
prerank,Regulatory circuits of the STAT3 signaling pathway WP4538,0.4675147708951525,1.759547439475723,0.0,0.023186878334760557,0.46,17/78,19.87%,OSMR;AKT1S1;MTOR;MAPK1;TYK2;RICTOR;MAPK3;RPTOR;EGFR;IL6ST;MAPK6;TRIM28;STMN1;SETD7;IFNAR1;MLST8;MAPK8
prerank,Kit receptor signaling pathway WP304,0.46293189044246497,1.7543340587412826,0.0,0.022740976828322854,0.46,19/59,22.98%,MAPK1;CBL;PLCG1;MAPK3;RPS6KB1;STAT1;PRKCA;AKT1;RPS6KA3;LYN;GRB10;RPS6;GRB2;MAPK8;EP300;BAD;CRK;SHC1;SOS1
prerank,Base Excision Repair WP4752,-0.4778117059518075,-1.7534950124432798,0.0,0.1393643031784841,0.49,12/31,17.44%,SMUG1;PCNA;NEIL3;FEN1;POLE;UNG;POLD1;POLE2;POLD3;PARP1;POLB;APEX2
prerank,Aryl Hydrocarbon Receptor Netpath WP2586,0.4755273845032673,1.741580333902889,0.0,0.02495410069046351,0.48,14/46,22.79%,NCOR2;VEGFA;CDK2;MAPK1;CYP1B1;RB1;EGFR;KLF6;KRAS;MYC;NRAS;EP300;CDKN1A;NQO1
prerank,Tumor suppressor activity of SMARCB1 WP4204,0.5492683072174116,1.7365867534725397,0.0,0.025356410810527627,0.48,7/31,13.61%,CDK6;RBBP4;PTCH1;RB1;ARID1A;H3F3B;CDKN2A
prerank,TGF-beta Signaling Pathway WP366,0.3726250242639715,1.7364546226236304,0.0,0.024895385159427123,0.48,46/132,26.78%,SMAD3;PAK2;TP53;SKP1;SKI;ROCK1;MAPK1;MET;TGFBR2;SP1;NUP153;APP;CDC42;THBS1;AKT1;RAC1;HDAC1;HGS;TGIF1;KLF6;MYC;PRKAR2A;SUMO1;PIAS1;MAP2K4;NEDD4L;GRB2;YAP1;MAP3K7;MAPK8;EP300;CAV1;KLF10;SHC1;SMAD2;CDKN1A;ITCH;SOS1;FN1;ITGB4;LIMK2;CCND1;SIN3A;JUND;PTK2;COPS5
prerank,Apoptosis WP254,0.39016476979555204,1.7362189630264397,0.0,0.02445082471015164,0.48,22/84,21.64%,MCL1;SCAF11;TP53;DFFA;BOK;BIRC2;MAP3K1;BNIP3L;PMAIP1;BCL2L2;AKT1;BIRC3;IRF3;BAX;CDKN2A;TNFRSF1A;MYC;MAP2K4;TRAF2;IGF1R;CASP4;BAD
prerank,Cannabinoid receptor signaling WP3869,0.5768128975822012,1.716748584963461,0.0,0.028935425733544684,0.55,9/29,19.87%,MAPK1;PRKAR1B;PRKACB;MAPK3;PRKAR1A;DAGLB;PRKACA;ADCY7;MAPK8
prerank,Ebola Virus Pathway on Host WP4217,0.39057888507292976,1.7078804180784593,0.0,0.029509616029493358,0.56,33/129,20.58%,ITGA3;CLTB;FLNA;AXL;NEDD4;ACTG1;ACTN4;FLNB;MAPK1;MAPK3;FLNC;KPNA1;CDC42;PAK1;EIF2AK2;STAT1;AKT1;RAC1;IRF3;EGFR;PIK3CB;RHOC;CLTC;PIK3CA;ACTB;GAS6;HLA-DQB1;MFGE8;EP300;DAB2IP;IGF1R;CAV1;NPC2
prerank,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.5545255934018476,1.7053973757391834,0.0,0.029800619947195604,0.57,7/22,15.62%,MCL1;BOK;GSK3B;BCL2L2;AKT1;BAX;MYC
prerank,Interferon type I signaling pathways WP585,0.44329029414486437,1.7016441167581902,0.0,0.03060057759179584,0.58,17/54,19.22%,MTOR;PRMT1;CBL;TYK2;RPS6KB1;RACK1;MAP3K1;EIF4A1;STAT1;RPTOR;RAC1;EIF4B;RPS6;RAP1A;PIAS1;IFNAR1;MLST8
prerank,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.5483683148781144,1.7014061657380974,0.0,0.03009892877881558,0.58,6/27,16.34%,KIF1B;RAB11A;MFN2;NDRG1;DNM2;HSPB1
prerank,Parkin-Ubiquitin Proteasomal System pathway WP2359,-0.3950628604531357,-1.6993924341628628,0.0,0.13810876891561488,0.58,14/70,13.91%,TUBB4B;TUBA1B;PSMD13;CCNE1;SIAH2;PSMD1;HSPA14;PSMD6;PSMD14;HSPA9;PSMC4;PSMD11;TUBB6;TUBB
prerank,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.35115387125755415,1.6982662241723947,0.0,0.030366346817446387,0.58,57/303,24.45%,PPP2R5E;OSMR;ATF4;ITGA3;PIK3C2A;LAMA5;AKT3;AKT1S1;LAMB1;SLC2A1;VEGFA;GNB1;PPP2R1A;MTOR;MAPK1;MET;PRKAA1;SPP1;GNG5;MAPK3;RPS6KB1;CREB3L2;THBS1;GSK3B;CSF1;AKT1;RPTOR;EGFR;EIF4B;KRAS;EIF4E2;PIK3CB;HSP90B1;RPS6;PIK3CA;NRAS;LAMC2;GYS1;GNG12;LAMB2;FOXA1;COL6A2;IFNAR1;CREB3;GRB2;MLST8;VEGFC;IGF1R;BAD;CDKN1A;GNB2;SOS1;AKT2;RHEB;LAMA4;FN1;ITGB4
prerank,16p11.2 proximal deletion syndrome WP4949,0.41365702025663376,1.6982357558792698,0.0,0.029884341312407556,0.58,20/74,20.65%,CCT5;TAOK2;TP53;PPP2R1A;KMT2D;EZR;MAPK3;TCP1;GDPD3;CCT3;NR3C1;CCDC6;HIRA;ALDOA;PPP4R3B;PPP4C;IGFBP3;TRAF2;MAZ;PARP4
prerank,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.43492240121127507,1.696431636379707,0.0,0.029660517475098718,0.59,21/95,23.25%,RXRA;AKT3;AKT1S1;KDM1A;TP53;MTOR;MAPK1;RPS6KB1;MGLL;GSK3B;RPTOR;CTNNB1;RPS6;PIK3CA;PRKACA;CREB3;GRB2;MLST8;BAD;SOS1;RHEB
prerank,Breast cancer pathway WP4262,0.39223968446808594,1.6964132274437613,0.0,0.02920420182163566,0.59,40/154,26.39%,CDK6;AKT3;SHC3;TP53;NOTCH2;SKP1;MTOR;MAPK1;SP1;MAPK3;DVL3;RPS6KB1;CSNK2A2;GSK3B;RB1;AKT1;NBN;BAX;EGFR;KRAS;CTNNB1;MYC;PIK3CA;NRAS;ATR;CSNK1A1;RAD50;GRB2;IGF1R;DVL1;CSNK2A1;SHC1;CDKN1A;SOS1;AKT2;PIK3R3;CCND1;NFKB2;GADD45A;CETN3
prerank,Small cell lung cancer WP4658,0.392725582729951,1.6950191509056058,0.0,0.028761713915247244,0.59,30/96,26.68%,ITGA3;CDK6;LAMA5;RXRA;AKT3;LAMB1;TP53;CDK2;SKP1;BIRC2;COL4A5;RB1;AKT1;BIRC3;BAX;PIK3CB;MYC;PIK3CA;LAMC2;LAMB2;TRAF2;CDKN1A;AKT2;PIK3R3;LAMA4;FN1;CCND1;GADD45A;PTK2;IKBKG
prerank,TGF-beta Receptor Signaling WP560,0.4579144526098043,1.6918008367189097,0.0,0.029029133814630508,0.6,14/54,22.44%,SMAD3;SKI;TGFBR2;SPP1;MAPK3;THBS1;STAT1;TGIF1;CTNNB1;FKBP1A;ENG;EP300;SMAD2;INHBA
prerank,Prolactin Signaling Pathway WP2037,0.40275010941910816,1.688728878126547,0.0,0.029288688422855442,0.61,24/76,22.98%,FLNA;MTOR;YWHAZ;MAPK1;CBL;MAPK3;RPS6KB1;PAK1;YWHAG;STAT1;GSK3B;CTSD;AKT1;RAC1;PIK3CB;PPIA;MYC;RPS6;PIK3CA;GRB2;PXN;MAPK8;SHC1;SOS1
prerank,Complement system WP2806,0.462194243143254,1.6860435658560606,0.0,0.029991723063440286,0.62,14/97,19.84%,LAMA5;CFD;LAMB1;SPP1;CD59;THBS1;PRKCA;RPS19;GNAI2;CD55;PRKACA;CSNK1A1;C3;C1S
prerank,Spinal Cord Injury WP2431,0.4142395570752507,1.6843544301512137,0.017857142857142856,0.030007830326095195,0.62,17/118,16.13%,TP53;CDK2;ANXA1;KLK8;MAPK1;MAPK3;CDC42;NTN1;RB1;PRKCA;RAC1;CD47;EGFR;CCNG1;RHOC;MYC;FKBP1A
prerank,Pancreatic adenocarcinoma pathway WP4263,0.4067840757361086,1.6821596789091917,0.0,0.030242633380289992,0.62,30/89,23.53%,CDK6;SMAD3;PAK2;AKT3;VEGFA;TP53;MTOR;MAPK1;TGFBR2;MAPK3;RPS6KB1;CDC42;PAK1;STAT1;RB1;AKT1;RAC1;BAX;EGFR;KRAS;CDKN2A;PIK3CB;PIK3CA;RALA;MAPK8;BAD;SMAD2;CDKN1A;AKT2;PIK3R3
prerank,Nonalcoholic fatty liver disease WP4396,0.3700121961297606,1.6801307168836306,0.0,0.03003870257951711,0.63,44/155,25.02%,ATF4;RXRA;AKT3;NDUFB7;COX6A1;COX6B1;NDUFA4;NDUFC2;COX4I1;PRKAA1;UQCRB;CDC42;SDHA;GSK3B;AKT1;PRKAB1;RAC1;COX5A;NDUFB2;BAX;UQCRC2;VMP1;NDUFS5;NDUFS2;PIK3CB;TNFRSF1A;COX7A2;PIK3CA;MLX;UQCR10;TRAF2;MAPK8;UQCR11;NDUFA5;NDUFC1;COX7C;ITCH;AKT2;UQCRQ;PIK3R3;NDUFA1;NDUFB6;NDUFA13;NDUFA10
prerank,DNA Mismatch Repair WP531,-0.49594552450932183,-1.6773535912435,0.024390243902439025,0.1195896385382938,0.63,13/23,28.24%,PCNA;POLE;MSH2;POLD1;RFC5;POLE2;POLD3;RFC2;MSH6;RFC3;EXO1;RFC4;POLE3
prerank,RANKL/RANK signaling pathway WP2018,0.47037177594098567,1.6748432573760923,0.0,0.029840358923970873,0.63,19/55,26.68%,MTOR;MAPK1;CBL;PLCG1;MAPK3;CDC42;STAT1;AKT1;RAC1;LYN;TAB2;TRAF2;MAP3K7;MAPK8;AKT2;SQSTM1;NFKB2;PTK2;IKBKG
prerank,Proteoglycan biosynthesis WP4784,-0.578856628377701,-1.673993946789973,0.0,0.09793167250379965,0.63,6/18,17.81%,SLC35B3;B4GALT7;EXTL3;PAPSS2;CHST3;XYLT2
prerank,DNA damage response (only ATM dependent) WP710,0.38098283878510825,1.6735015562729048,0.0,0.02985764098512375,0.63,36/110,25.41%,PPP2R5E;PIK3C2A;SMAD3;AKT3;TP53;MAPK1;DVL3;MAP3K1;CDC42;PIK3C3;PMAIP1;GSK3B;AKT1;RAC1;BAX;KRAS;CDKN2A;PIK3CB;CTNNB1;BIK;MYC;PIK3CA;NRAS;GRB2;MAP3K7;MAPK8;DVL1;BAD;SHC1;CDKN1A;SOS1;AKT2;PIK3R3;CCND1;PPP2R5C;NFKB2
prerank,Pathogenic Escherichia coli infection WP2272,0.4150046601623584,1.6724578893750408,0.0,0.02966700064831732,0.63,14/55,16.51%,WASL;CTTN;ACTG1;YWHAZ;ROCK1;CLDN1;EZR;CDC42;PRKCA;ARPC1B;ARPC3;CTNNB1;NCK1;ACTB
prerank,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.39818733167268583,1.667809773045627,0.017543859649122806,0.03091449966343335,0.64,27/158,20.26%,MECP2;VEGFA;YWHAZ;SP1;MBD1;PRKAR1B;PRKACB;HSPD1;NFYA;YWHAG;PRKAR1A;HDAC1;GATA2;NR3C1;ALDOA;TCF3;ECE1;CTNNB1;HSP90B1;PRKAR2A;HADHA;PRKACA;YWHAB;MAZ;YWHAE;VAMP2;EP300
prerank,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.5690197785034591,1.6636113573821092,0.0,0.0325337419697059,0.65,11/17,29.02%,EIF3CL;EIF3B;EIF3A;EIF3C;EIF2S3;EIF3I;EIF3E;EIF3H;EIF5;EIF1;EIF2S1
prerank,TNF-alpha signaling pathway WP231,0.3848365950860991,1.6602980037891222,0.0,0.0327150894723241,0.66,32/92,26.68%,PYGL;SKP1;MAPK1;MAPK3;BIRC2;MAP3K1;RFFL;AKT1;BIRC3;RFK;RAC1;BAX;PRKCZ;TANK;KRAS;TAB2;TNFRSF1A;TNFAIP3;NRAS;MAP2K4;PSMD2;GRB2;TRAF2;MAP3K7;MAPK8;BAD;CSNK2A1;SOS1;NFKB2;TAB3;HSP90AA1;IKBKG
prerank,Insulin Signaling WP481,0.35796884791602557,1.660277705663541,0.02040816326530612,0.032300974415712405,0.66,45/160,23.75%,PIK3C2A;PRKCI;KIF5B;SHC3;SLC2A1;MTOR;MAP3K2;MAPK1;CBL;PRKAA1;PTPRF;MAPK3;ARF1;RPS6KB1;EHD1;MAP3K1;PIK3C3;GSK3B;INPPL1;PRKCA;AKT1;RPS6KA3;RAC1;RHOQ;EHD2;MYO1C;PRKCZ;PIK3CB;GRB10;PIK3CA;MAPK6;GYS1;MAP2K4;GRB2;MAP3K7;MAPK8;VAMP2;IGF1R;CRK;SHC1;SOS1;AKT2;RHEB;PIK3R3;PRKCH
prerank,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.41990661795549455,1.658378976860565,0.0,0.032869688218306124,0.67,27/68,26.68%,TP53;MAPK1;MAPK3;PAK1;AKT1;RAC1;BAX;EGFR;KRAS;RASA1;CTNNB1;MYC;PIK3CA;NCK1;NRAS;STMN1;GRB2;PXN;YAP1;MAPK8;BAD;CRK;SOS1;FN1;MAPK11;PTK2;IKBKG
prerank,PDGF Pathway WP2526,0.450286878388361,1.6582186798872751,0.0,0.03265598361961891,0.67,15/40,22.98%,WASL;MAPK1;PLCG1;MAPK3;MAP3K1;CDC42;PAK1;STAT1;RAC1;RASA1;MAP2K4;GRB2;MAPK8;SHC1;SOS1
prerank,Endochondral Ossification WP474,0.46760147037694133,1.6560598381346379,0.0196078431372549,0.03205655769775631,0.67,11/64,20.46%,PTCH1;VEGFA;SLC38A2;SPP1;STAT1;AKT1;CALM2;PRKACA;CALM1;CHST11;IGF1R
prerank,Endochondral Ossification with Skeletal Dysplasias WP4808,0.46760147037694133,1.6560598381346379,0.0196078431372549,0.03205655769775631,0.67,11/64,20.46%,PTCH1;VEGFA;SLC38A2;SPP1;STAT1;AKT1;CALM2;PRKACA;CALM1;CHST11;IGF1R
prerank,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.41609112812855314,1.6474302631148108,0.03571428571428571,0.035194368900975846,0.71,22/66,26.59%,MAPK1;CBL;PLCG1;PAK1;GSK3B;AKT1;EGFR;CTNNB1;MYC;NCK1;MAP2K4;DAAM1;GRB2;MAPK8;DVL1;SHC1;CDKN1A;SOS1;FN1;ACTR2;ROCK2;PTK2
prerank,Androgen receptor signaling pathway WP138,0.3866815249233987,1.6445161073114676,0.0,0.035878643317997914,0.73,38/90,27.33%,NCOR2;SMAD3;FLNA;KDM1A;ROCK1;FKBP4;SIRT1;SP1;RACK1;CDC42;PARK7;GSK3B;RB1;NCOR1;NR2C2;AKT1;RAC1;HDAC1;TGIF1;EGFR;CTNNB1;NCOA4;PRDX1;SUMO1;PIAS1;STUB1;EP300;CAV1;DSTN;CDKN1A;PATZ1;LIMK2;CCND1;BAG1;ROCK2;SIN3A;PTK2;RNF6
prerank,miRNA regulation of prostate cancer signaling pathways WP3981,0.5085208613412628,1.6434934243682198,0.017241379310344827,0.03582330131952449,0.74,15/33,26.68%,AKT3;TP53;MTOR;MAPK1;GSK3B;KRAS;CTNNB1;PIK3CA;NFATC2IP;GRB2;BAD;CDKN1A;SOS1;CCND1;IKBKG
prerank,Integrated breast cancer pathway WP1984,0.3452252427114238,1.6399118348517872,0.0,0.03630577002416456,0.75,42/152,23.25%,TPR;HIPK2;CDC25B;VEGFA;TP53;CDK2;MTOR;ANXA1;UBE2F;MAPK1;TGFBR2;SIRT1;SP1;CSNK1D;CDC42;PAK1;STAT1;RB1;AKT1;RAC1;HDAC1;FAU;WEE1;BAX;EGFR;KRAS;ODC1;PPP4R3B;CTNNB1;MYC;RAP1A;PIAS1;ATR;GDI1;RAD50;RALA;FOSL2;EP300;BAD;SMAD2;CERK;RHEB
prerank,Thermogenesis WP4321,0.38142810236999863,1.6379788298328561,0.0,0.03660045971591914,0.76,27/108,19.23%,AKT1S1;KDM1A;ACTG1;MTOR;GNAS;PRKAA1;PRKACB;RPS6KB1;CREB3L2;MGLL;ARID1A;RPS6KA3;RPTOR;PRKAB1;ACSL1;KRAS;ADCY6;ACSL4;RPS6;PRKACA;ACTB;NRAS;CREB3;GRB2;ADCY7;MLST8;KDM3A
prerank,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.498165560313474,1.6292931465786131,0.023255813953488372,0.03951093431201215,0.78,11/39,23.75%,MAPK1;MAPK3;PRKCA;AKT1;KRAS;PIK3CB;PRKCG;PIK3CA;NRAS;AKT2;PRKCH
prerank,G1 to S cell cycle control WP45,-0.39908579839707264,-1.6204643461197352,0.024390243902439025,0.13120333046983415,0.82,21/64,16.79%,CREB1;MCM2;CCNE1;MCM6;PCNA;ORC1;CDC25A;E2F1;ATF6B;POLE;CCND3;MCM3;PRIM2;CDK1;PRIM1;E2F3;CDC45;POLE2;MCM5;CCNB1;ORC6
prerank,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.5564042108440365,1.6123867872415172,0.017857142857142856,0.0446042317439736,0.84,7/33,22.16%,MTOR;MAPK1;AKT1;BAX;TNFRSF1A;PIK3CA;SMAD2
prerank,Genes controlling nephrogenesis WP4823,0.5734077173930585,1.6084133265009877,0.019230769230769232,0.04565293844482858,0.84,8/43,17.36%,ITGA3;VEGFA;NOTCH2;CD2AP;KIRREL1;CTNNB1;NCK1;LAMB2
prerank,PDGFR-beta pathway WP3972,0.456332365707192,1.59899813494352,0.038461538461538464,0.048370109752691286,0.85,13/29,22.98%,PLCG1;MAPK3;MAP3K1;EIF2AK2;STAT1;PRKCA;RASA1;PIK3CA;MAP2K4;GRB2;MAPK8;SHC1;SOS1
prerank,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.35801004682807075,1.5941451186739475,0.0196078431372549,0.05035961648513148,0.88,44/132,30.53%,PIK3C2A;RXRA;SHC3;SLC2A1;MTOR;MAP3K2;MAPK1;CBL;PRKAA1;RICTOR;MAPK3;RPS6KB1;MAP3K1;PIK3C3;GSK3B;AKT1;RPS6KA3;RPTOR;PRKAB1;RHOQ;PIK3CB;PIK3CA;MAPK6;GYS1;MAP2K4;FASN;MLST8;MAP3K7;MAPK8;CRK;SHC1;SOS1;AKT2;RHEB;PIK3R3;TRIP10;MAPK11;RPS6KA1;PDPK1;MINK1;PIK3R4;SCD;PIK3R2;IRS2
prerank,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.36020952362378483,1.593906671900887,0.02040816326530612,0.049989403711083714,0.88,24/144,10.64%,IGF2BP1;SHC3;MTOR;MAP3K2;MAPK1;PLCG1;PRKAA1;SPP1;PTPRF;CFL1;CYFIP1;MAPK3;RPS6KB1;RACK1;MAP3K1;SORT1;CDC42;STAT1;DLG1;GSK3B;CDK5;AKT1;RPS6KA3;RAC1
prerank,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.5273829627417483,1.586379295963232,0.0,0.05273890803510219,0.89,8/29,17.68%,PLCG1;GSK3B;PRKCA;AKT1;CALM2;RASA1;CALM1;CSNK1A1
prerank,Bladder cancer WP2828,0.4496423477260799,1.583386966362516,0.02,0.05332409972299169,0.9,11/40,16.64%,VEGFA;TP53;MAPK1;DAPK1;THBS1;RB1;EGFR;KRAS;CDKN2A;MYC;NRAS
prerank,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.40326483880022784,1.5818319582166038,0.016666666666666666,0.0530951835552215,0.9,20/66,17.59%,GNA12;CDK2;GNB1;MTOR;MAPK1;GNAS;MYL12B;MAPK3;RPS6KB1;STAT1;RB1;AKT1;GNAI2;RAP1B;RAP1GAP;MYC;RPS6;RAP1A;PIK3CA;GNA13
prerank,Endometrial cancer WP4155,0.4355908770643959,1.5785894861717729,0.017857142857142856,0.05398234026916596,0.9,24/63,27.11%,AKT3;TP53;MAPK1;MAPK3;GSK3B;AKT1;BAX;EGFR;KRAS;PIK3CB;CTNNB1;MYC;PIK3CA;NRAS;GRB2;BAD;CDKN1A;SOS1;AKT2;PIK3R3;CCND1;CTNNA1;GADD45A;PDPK1
prerank,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.501050045639821,1.5742535156447566,0.043478260869565216,0.05532307813206028,0.93,7/35,25.41%,VEGFA;BIRC2;BCL2L2;BIRC3;TNFRSF1A;CCND1;NFKB2
prerank,Pathways in clear cell renal cell carcinoma WP4018,0.37876610144984374,1.5704022791354655,0.03571428571428571,0.05694819355218954,0.93,23/85,23.87%,AKT1S1;GPI;SLC2A1;VEGFA;MTOR;PFKP;SETD2;AKT1;RPTOR;HK1;EGFR;KDM5C;ALDOA;PKM;GRB10;FASN;ENO1;MLST8;ACLY;EP300;RHEB;SQSTM1;BHLHE41
prerank,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.40068480843426124,1.554974845868773,0.05454545454545454,0.06223846289856781,0.93,21/44,30.32%,MECP2;AKT1S1;MTOR;PRKAA1;PIK3C3;RPTOR;ATG5;BECN1;GTPBP2;ATP13A2;MLST8;FTL;RHEB;WIPI2;ATG13;SPTLC1;STK11;PIK3R4;COASY;ATG12;ATG16L1
prerank,Circadian rhythm related genes WP3594,0.32354296462550586,1.5547880556254647,0.0,0.06162828188975832,0.93,45/201,28.10%,ATF4;SETX;SFPQ;ARNTL2;TP53;CSNK1E;HNRNPU;PPP1CA;SKP1;OGT;HDAC2;DBP;GFPT1;THRAP3;SIRT1;PRKAA1;CSNK1D;GSK3B;NCOR1;DDX5;NONO;HEBP1;HDAC1;RPS27A;CRY1;PRKCG;CST3;NAMPT;KDM5A;RBM4;PSPC1;ATF5;MAPK8;EP300;KLF10;CIPC;MAGED1;BHLHE41;HNRNPD;ROCK2;SIN3A;JUND;ADA;RAI1;GNA11
prerank,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.36810400960685496,1.5543476859494196,0.03278688524590164,0.061332077516549836,0.93,25/73,25.67%,SMAD3;AKT3;MSH3;TP53;MAPK1;TGFBR2;MAPK3;NTN1;PMAIP1;GSK3B;AKT1;RAC1;BAX;KRAS;CTNNB1;MYC;CSNK1A1;RALA;MAPK8;BAD;SMAD2;CDKN1A;AKT2;CCND1;GADD45A
prerank,Microglia Pathogen Phagocytosis Pathway WP3937,0.5428194975648893,1.5526337727091262,0.022222222222222223,0.06149040445026772,0.93,7/40,16.03%,PIK3C2A;PIK3C3;RAC1;ARPC1B;LYN;PIK3CB;PIK3CA
prerank,Oncostatin M Signaling Pathway WP2374,0.39532335510519295,1.5512457825217596,0.020833333333333332,0.06105296836716652,0.93,21/65,23.75%,OSMR;VEGFA;TP53;CDK2;MTOR;MAPK1;TYK2;RICTOR;MAPK3;STAT1;PRKCA;AKT1;KRAS;IL6ST;RPS6;GRB2;PXN;MAPK8;SHC1;SOS1;PRKCH
prerank,DNA IR-damage and cellular response via ATR WP4016,-0.3665068614619529,-1.5501072889376843,0.0,0.18940631165570043,0.94,35/80,29.03%,UIMC1;MCM2;CLK2;PCNA;RAD51;FEN1;E2F1;USP1;CLSPN;MSH2;MDC1;RAD9A;CDK1;CDC45;FANCD2;FANCI;CHEK1;PARP1;POLB;RAD1;RFWD3;RAD52;BRCA1;FOXM1;FANCA;TOP3A;UPF1;SMC1A;EXO1;EEF1E1;CDC25C;PLK1;RBBP8;BCL6;H2AFX
prerank,BDNF-TrkB Signaling WP3676,0.47483826501219617,1.5490272798844493,0.0196078431372549,0.06179809641579492,0.95,12/34,23.25%,MTOR;MAPK1;PLCG1;RPS6KB1;AKT1;KRAS;MKNK1;NRAS;GRB2;SHC1;SOS1;RHEB
prerank,Hippo-Merlin Signaling Dysregulation WP4541,0.3666250657320009,1.5472965152161278,0.0,0.06194762895978946,0.96,26/120,24.91%,ITGA3;PAK2;PPP1CA;MET;PRKAR1B;PRKACB;PPP1R12A;TEAD1;PAK1;PRKAR1A;EGFR;KRAS;CTNNB1;MYC;PRKAR2A;PRKACA;NRAS;CD44;NF2;IGF1R;STK3;SAV1;LATS2;ITGB4;CCND1;CTNNA1
prerank,Alzheimer's disease WP2059,0.3844458569906237,1.5415502230302591,0.019230769230769232,0.06324695651035016,0.97,15/83,17.09%,CAPN1;CALML5;TP53;ADAM10;MAPK1;MAPK3;APP;ITPR3;GSK3B;CDK5;VMP1;CALM2;TNFRSF1A;CALM1;CALM3
prerank,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.3984683088172456,1.5378663687623342,0.0392156862745098,0.06409419688407555,0.98,19/71,26.20%,RXRA;MAPK1;SP1;TYK2;MAPK3;STAT1;PRKCA;PRKCZ;KRAS;PRKCG;TNFRSF1A;MED1;NRAS;MAPK8;CAV1;PRKCH;NFKB2;SP3;MAPK11
prerank,Nucleotide metabolism WP404,-0.4641992115236709,-1.5372937290294726,0.0392156862745098,0.1784428071102888,0.94,11/19,38.29%,RRM1;POLD1;POLB;PRPS1;POLA1;ADSS;PRPS2;OAZ1;RRM2;HPRT1;ADSL
prerank,Pyrimidine metabolism WP4022,-0.3542351743169621,-1.53470093342624,0.0,0.16070838564726098,0.94,29/85,28.24%,CTPS2;POLR1A;DCTPP1;POLR3GL;UCKL1;RRM1;POLE;POLR3K;NME7;PNPT1;PRIM2;POLD1;PRIM1;POLE2;NME1;POLR3A;POLD3;UMPS;CAD;POLA1;DPYD;UCK2;POLR1B;ZNRD1;POLR3F;POLR3C;POLR3B;NME1-NME2;POLE3
prerank,Melatonin metabolism and effects WP3298,0.5484948657606736,1.5344541052040515,0.046511627906976744,0.0647845818353274,0.98,10/37,16.65%,CSNK1E;SIRT1;CYP1B1;CSNK1D;GSK3B;PRKCA;CRY1;CALM2;ECE1;CALM1
prerank,"GPCRs, Class A Rhodopsin-like WP455",-0.5092893473880057,-1.532278334780506,0.06382978723404255,0.14614418819797795,0.94,6/257,21.63%,ADORA2B;HTR1D;F2RL1;OPN3;LPAR5;P2RY6
prerank,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.4479099800588002,1.5296837384531345,0.037037037037037035,0.0661634110092883,0.98,8/47,12.45%,ATF4;PPP1R12C;PPP1CA;PPP1R12A;EIF2AK1;EIF2AK2;PPP1R14B;PPP1R15B
prerank,Nephrotic syndrome WP4758,0.43858812950822945,1.528363370411733,0.03773584905660377,0.06571159140853253,0.98,8/45,8.54%,ITGA3;LMNA;ACTN4;YARS;MYH9;CD2AP;ANLN;COL4A5
prerank,NRF2 pathway WP2884,0.3518162823828881,1.5260836173000538,0.0,0.06609394290113396,0.98,22/146,17.88%,SLC2A8;RXRA;GPX2;SLC2A1;PGD;PRDX6;TGFBR2;ALDH3A1;BLVRB;MAFG;UGT1A6;KEAP1;ABCC3;FTH1;GSTM3;SLC5A6;GPX3;PRDX1;SLC39A6;SLC7A11;PTGR1;UGT1A3
prerank,EPO Receptor Signaling WP581,0.49252808519083024,1.524325517280083,0.019230769230769232,0.06619661075834514,0.98,9/26,22.98%,MAPK1;MAPK3;PTPRU;STAT1;AKT1;RASA1;GRB2;SHC1;SOS1
prerank,Vitamin D-sensitive calcium signaling in depression WP4698,0.5225477777743753,1.5235692899018916,0.08888888888888889,0.06589159006870113,0.98,5/41,9.08%,RXRA;KDM1A;ITPR3;ATP2B1;ATP2B4
prerank,One-carbon metabolism WP241,-0.48861755733264267,-1.5228169697712475,0.06818181818181818,0.14381574283774773,0.96,6/30,18.83%,SHMT1;MTRR;MTHFD1L;DNMT1;MTHFD1;TCN2
prerank,Hepatitis B infection WP4666,0.34300735701832874,1.5214319756666623,0.019230769230769232,0.06586009759309654,0.98,38/152,23.53%,ATF4;SMAD3;AKT3;YWHAZ;MAPK1;TGFBR2;TYK2;MAPK3;MAP3K1;CREB3L2;STAT1;PRKCA;AKT1;IRF3;BAX;KRAS;TAB2;PIK3CB;PRKCG;MYC;ATP6AP1;PIK3CA;NRAS;YWHAB;MAP2K4;IFNAR1;CREB3;GRB2;MAP3K7;MAPK8;EP300;DDX3X;BAD;SMAD2;CDKN1A;SOS1;AKT2;PIK3R3
prerank,Fas ligand pathway and stress induction of heat shock proteins WP314,0.4238696948245363,1.514463050909196,0.022222222222222223,0.06848890682214193,0.98,13/42,19.87%,LMNA;PAK2;ACTG1;DFFA;MAP3K1;PAK1;RB1;HSPB1;ACTB;MAP2K4;RIPK2;MAP3K7;MAPK8
prerank,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.32536958033648283,1.5039073428754042,0.0,0.07344666066631837,0.98,36/160,26.20%,RBBP4;SMAD3;AKT3;DSP;TP53;NOTCH2;CLDN1;MAPK1;TGFBR2;MAPK3;PAK1;SPARC;COL4A5;GSK3B;NR2C2;AKT1;PDCD6;KRAS;PIK3CB;CTNNB1;PIK3CA;FMNL2;WNT9A;MAP2K4;GRB2;MAPK8;SHC1;SMAD2;LATS2;SOS1;AKT2;PIK3R3;FN1;CTDSP1;RBPJ;MAPK11
prerank,Resistin as a regulator of inflammation WP4481,0.47276676969192716,1.5003546317186116,0.07272727272727272,0.07479075793693443,0.98,7/33,16.03%,AKT3;MAPK1;PLCG1;MAPK3;AKT1;PIK3CB;PIK3CA
prerank,Cardiac Hypertrophic Response WP2795,0.40428138983263445,1.4973377172540376,0.02,0.07546413626451347,0.98,14/55,19.87%,MTOR;MAPK1;MAPK3;MAP3K1;GSK3B;PRKCA;AKT1;RAC1;CALM2;TNFRSF1A;CALM1;MAP2K4;MAP3K7;MAPK8
prerank,Netrin-UNC5B signaling pathway WP4747,0.40496237159760995,1.4930463239950997,0.017857142857142856,0.07754089489222395,0.98,12/52,19.21%,TP53;PPP1CA;MAPK1;MAPK3;DAPK1;NTN1;PRKCA;AKT1;RAC1;PIK3CA;RLF;YAP1
prerank,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.33457763428743664,1.4889768210304641,0.0,0.07869084345986956,0.98,29/103,26.62%,ATP5PD;NDUFB7;COX6A1;COX6B1;ATP5MF;NDUFA4;NDUFC2;COX4I1;UQCRB;SDHA;COX5A;NDUFB2;UQCRC2;NDUFS5;ATP5PB;NDUFS2;COX7A2;UQCR10;ATP5IF1;UQCR11;NDUFA5;NDUFC1;COX7C;UQCRQ;NDUFA1;NDUFB6;NDUFA10;ATP5F1B;ATP5MG
prerank,ATM Signaling Pathway WP2516,-0.4160022222643312,-1.48414774776137,0.02127659574468085,0.1723220775788013,0.98,15/40,20.23%,CREB1;RIPK1;CCNE1;RAD51;CDC25A;MDC1;RAD9A;NFKBIA;CDK1;FANCD2;CHEK1;CCNB1;ATF2;JUN;BRCA1
prerank,IL-6 signaling pathway WP364,0.4235481652170605,1.4836359486220267,0.02,0.0810871030853292,0.98,17/43,25.12%,MAPK1;TYK2;MAPK3;RPS6KB1;STAT1;GSK3B;AKT1;RAC1;HDAC1;IL6ST;MAP2K4;GRB2;MAP3K7;BAD;SHC1;SOS1;NLK
prerank,Wnt signaling pathway and pluripotency WP399,0.3553686903485178,1.4831619622729624,0.018518518518518517,0.08080961715055981,0.98,26/102,25.23%,PPP2R5E;PRKCI;TP53;CSNK1E;PPP2R1A;DVL3;FBXW2;NFYA;GSK3B;PAFAH1B1;PRKCA;PRKCZ;PRKCG;CTNNB1;CTBP1;MYC;MAP2K4;MAP3K7;CD44;EP300;CTNND1;DVL1;PRKCH;CCND1;NLK;PPP2R5C
prerank,7q11.23 copy number variation syndrome WP4932,0.3325017979800502,1.4793250141397498,0.0,0.08252820180350091,0.99,21/104,15.62%,ATF4;HDAC2;CLDN1;OGDH;CFL1;DLD;MAPK3;LIMK1;SMARCA5;RB1;MVB12A;EIF2A;BECN1;MYO1C;BRD4;DEK;SF3B1;ATP5PB;CTNNB1;CLTC;MYC
prerank,DNA Repair Pathways Full Network WP4946,-0.31522634710765535,-1.4783811395979014,0.0,0.16631000005083135,0.98,43/120,30.00%,SMUG1;GTF2H4;NHEJ1;PCNA;NEIL3;RBX1;RAD51;FEN1;POLE;USP1;ERCC2;UNG;ERCC5;MSH2;POLD1;DCLRE1C;RFC5;FANCF;FANCD2;POLE2;FANCI;CHEK1;FANCC;POLD3;PARP1;POLB;APEX2;RFC2;RAD52;BRCA1;MSH6;FANCA;RFC3;EXO1;RFC4;PARP2;DDB1;ERCC6;CDK7;POLE3;H2AFX;CENPX;XPC
prerank,Genes related to primary cilium development (based on CRISPR) WP4536,-0.3562457837526125,-1.4775944030076453,0.037037037037037035,0.15469975738924394,0.98,12/103,17.00%,FUZ;TMEM216;IFT122;WDR34;IFT46;CEP76;ARL6;KATNB1;OFD1;INPP5E;BBS10;DYNLL1
prerank,Leptin signaling pathway WP2034,0.36368291949531284,1.466952461460268,0.01818181818181818,0.08767719971822052,0.99,27/76,26.87%,MTOR;ROCK1;MAPK1;SP1;PLCG1;PRKAA1;MAPK3;RPS6KB1;CDC42;STAT1;GSK3B;AKT1;KPNA4;RAC1;BAX;RPS6;GRB2;MAPK8;KHDRBS1;BAD;SHC1;SOS1;CCND1;ROCK2;PTK2;IKBKG;RPS6KA1
prerank,Mitochondrial CIV Assembly WP4922,0.4179937073457443,1.4573403387133994,0.02,0.09237756107385851,0.99,13/35,32.40%,COX6A1;COX6B1;NDUFA4;COX4I1;COX5A;COX16;COX7A2;COX7C;HIGD1A;COX14;COA3;COX5B;COX15
prerank,Osteoblast differentiation WP4787,0.37934992601307965,1.4548537638043701,0.05555555555555555,0.09299301585430542,0.99,25/118,30.14%,PIK3C2A;PRKCI;PTCH1;NOTCH2;MAPK1;MAPK3;PIK3C3;STAT1;PRKCA;PRKCZ;PIK3CB;PRKCG;CTNNB1;PIK3CA;MAPK6;WNT9A;MAPK8;PIK3R3;PRKCH;RBPJ;MAPK11;PIK3C2B;LRP5;PIK3R4;PIK3R2
prerank,Senescence and Autophagy in Cancer WP615,0.32988162967662416,1.4520282612716575,0.04,0.09335769434785171,0.99,27/105,24.34%,SMAD3;CDC25B;AKT1S1;TP53;MTOR;MAPK1;BMI1;THBS1;PIK3C3;SPARC;GSK3B;RB1;SH3GLB1;RSL1D1;GABARAP;ATG5;BECN1;CDKN2A;IL6ST;IGFBP3;MLST8;CD44;IGF1R;CDKN1A;INHBA;SQSTM1;FN1
prerank,MECP2 and Associated Rett Syndrome WP3584,0.38414791900146816,1.4488130623602395,0.08333333333333333,0.09419551980994781,0.99,10/72,10.80%,TET3;MECP2;FUS;MTOR;HNRNPH1;SP1;NCOR1;CNP;AKT1;HDAC1
prerank,Nucleotide Excision Repair WP4753,-0.3674346510843028,-1.4450746001512236,0.04878048780487805,0.18129914755831628,1.0,18/44,30.00%,GTF2H4;PCNA;RBX1;POLE;ERCC2;ERCC5;POLD1;RFC5;POLE2;POLD3;RFC2;RFC3;RFC4;DDB1;ERCC6;CDK7;POLE3;XPC
prerank,Signaling of Hepatocyte Growth Factor Receptor WP313,0.39810736733899416,1.442207820366458,0.04081632653061224,0.0977523949723689,0.99,15/34,27.03%,MAPK1;MET;MAPK3;PAK1;RAP1B;RASA1;RAP1A;PIK3CA;GRB2;PXN;MAPK8;CRK;SOS1;PTK2;CRKL
prerank,Corticotropin-releasing hormone signaling pathway WP2355,0.36658580985899547,1.4421275264747377,0.0625,0.09701184652560853,0.99,18/93,19.87%,PRKCI;GNB1;MAPK1;SP1;PLCG1;GNAS;MAPK3;GSK3B;PRKCA;AKT1;GNB5;GNAI2;RAP1B;ECE1;CTNNB1;TRIM28;FOSL2;MAPK8
prerank,Glycogen Synthesis and Degradation WP500,0.4268054269753413,1.4410759608899708,0.043478260869565216,0.09686738210528975,0.99,12/40,17.09%,PPP2R5E;PYGL;AGL;PPP2R1A;PHKB;GSK3B;HK1;CALM2;UGP2;CALM1;GYS1;CALM3
prerank,IL-3 signaling pathway WP286,0.3875859901035015,1.4410271941605952,0.05555555555555555,0.09614449119405624,0.99,12/49,22.98%,MAPK1;CBL;MAPK3;AKT1;LYN;PRKACA;YWHAB;GRB2;MAPK8;BAD;SHC1;SOS1
prerank,Acute viral myocarditis WP4298,0.36370570052493323,1.4401214358621988,0.0392156862745098,0.09635436108000497,0.99,19/86,25.41%,ABL2;DFFA;MAPK1;MAPK3;STAT1;GSK3B;AKT1;EIF4G2;BAX;CD55;RASA1;PABPC1;ACTB;CAV1;SOS1;KRT8;EIF4G1;CCND1;NFKB2
prerank,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.4081150847421888,1.440115967830099,0.06,0.0956458731308873,0.99,14/46,22.98%,SMAD3;KIF5B;PLEC;MAPK1;SUN1;CFL1;MAPK3;KRAS;ADCY6;NRAS;GRB2;ADCY7;SMAD2;SOS1
prerank,AMP-activated protein kinase (AMPK) signaling WP1403,0.3775227828322367,1.429995937413351,0.05084745762711865,0.10221645366553107,0.99,17/69,23.53%,TP53;MTOR;PRKAA1;PRKACB;RPS6KB1;PIK3C3;AKT1;RPTOR;PRKAB1;STRADB;PIK3CB;PIK3CA;GYS1;FASN;CDKN1A;AKT2;PIK3R3
prerank,Zinc homeostasis WP3529,-0.4204850157859569,-1.4219070294954117,0.044444444444444446,0.1979820590761911,1.0,9/36,19.67%,MT1X;SLC39A13;MT1G;MT1A;SLC30A1;MT1F;SLC39A9;MT2A;SLC39A14
prerank,Notch Signaling WP268,0.4037421175956002,1.420474762873229,0.0425531914893617,0.10846630671815623,1.0,12/45,25.42%,NCOR2;MFNG;NOTCH2;HDAC2;DVL3;HDAC1;CTBP1;DVL1;NUMBL;RFNG;DTX3L;RBPJ
prerank,IL-5 signaling pathway WP127,0.4215769325928453,1.419376032348063,0.06,0.1082456719836602,1.0,13/40,22.98%,MAPK1;MAPK3;RPS6KB1;STAT1;GSK3B;AKT1;KRAS;LYN;MYC;RPS6;GRB2;SHC1;SOS1
prerank,Ectoderm Differentiation WP2858,0.33256191990901446,1.4155010432019388,0.0,0.11069555186959561,1.0,20/138,21.74%,MECP2;KRT6A;C1GALT1;OGT;KIFC3;TRIM33;BAZ1A;RRBP1;TTC14;PTPRB;TCF3;CTNNB1;CTBP1;MYC;RHPN1;STX16;NF2;PHF8;NR2F2;TSC22D1
prerank,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.44561467435365243,1.4146438095328797,0.06976744186046512,0.1105725883410726,1.0,8/18,19.25%,HNRNPH1;MAPK1;MAPK3;PDCD6IP;HGS;KRAS;NRAS;RRAS2
prerank,Ciliopathies WP4803,-0.31142522201885453,-1.4058918098812083,0.0,0.20383968032465086,1.0,24/183,27.00%,TMEM216;IFT122;WDR34;TMEM237;CCNQ;NME7;RAB28;NEK2;ARL6;FLCN;ARL2BP;XPNPEP3;OFD1;GLI2;INPP5E;BBS10;KIAA0556;POC1A;RSPH3;CFAP298;LZTFL1;PLK4;TCTN3;TMEM138
prerank,Endoderm differentiation WP2853,-0.2962770403123262,-1.4026996411376607,0.044444444444444446,0.19795590211238132,1.0,21/141,16.64%,TCF4;RARG;SFRP1;PBX1;DAB2;DUSP4;SIAH2;GRHL2;TRIM5;TCF7;AEBP2;JARID2;DUSP5;C1QBP;ZNF281;NOG;RGS10;SOX7;GLI2;MAP2K3;NME1
prerank,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.4376841226289656,1.3990988284121977,0.05454545454545454,0.1218471315901539,1.0,5/27,11.25%,MAPK1;MAPK3;STAT1;CNP;ATG5
prerank,Cell migration and invasion through p75NTR WP4561,0.45976095039340015,1.398887181670486,0.09259259259259259,0.12132147925157886,1.0,6/30,10.64%,TRIO;AKT3;ARF1;PAK1;AKT1;RAC1
prerank,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.38120048873293916,1.3966136366830522,0.11320754716981132,0.12242392094457871,1.0,10/35,22.97%,TEAD1;NDRG1;RAC1;MOB1A;VMP1;RAP1A;YAP1;STK3;SAV1;LATS2
prerank,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.34143988173626133,1.39383878068175,0.041666666666666664,0.12340384885060861,1.0,19/53,26.59%,PAK2;MAPK1;HSPD1;APP;RPS6KB1;THBS1;AKT1;HDAC1;ERBB3;YBX3;HSPB1;CUL5;RIPK2;CDKN1A;NQO1;SQSTM1;CTNNA1;JUND;PTK2
prerank,Integrated Cancer Pathway WP1971,0.4164847856238127,1.3859641457788214,0.09433962264150944,0.12788725253130373,1.0,14/44,22.22%,SMAD3;CDC25B;TP53;CDK2;STAT1;RB1;AKT1;BAX;MYC;ATR;RAD50;BAD;SMAD2;CDKN1A
prerank,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.41974274520305804,1.382060633229158,0.09090909090909091,0.1298751598240522,1.0,4/35,11.00%,H2AFV;MAPK1;MAPK3;H3F3B
prerank,Regulation of toll-like receptor signaling pathway WP1449,0.321390097194842,1.3788610975618203,0.02127659574468085,0.13089001065661643,1.0,29/139,26.68%,AKT3;RNF216;TMED7;MAPK1;SPP1;MAPK3;STAT1;AKT1;RAC1;IRF3;FBXW5;TAB2;PIK3CB;SIGIRR;PIK3CA;TNFAIP3;MAP2K4;IFNAR1;MLST8;MAP3K7;MAPK8;AKT2;ZMYND11;PIK3R3;SQSTM1;NFKB2;MAPK11;TAB3;IKBKG
prerank,Estrogen signaling pathway WP712,0.43434194205869436,1.3714233627069212,0.09259259259259259,0.13732144079130312,1.0,7/23,16.27%,GNB1;MAPK1;SP1;GNAS;AKT1;PIK3CA;PRKACA
prerank,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.3912710312961711,1.3702498292842997,0.04081632653061224,0.13754700300583483,1.0,10/47,16.03%,MTOR;MAPK1;MAPK3;STAT1;AKT1;LYN;YES1;MYC;RPS6;PIK3CA
prerank,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.3824190980420422,1.3666808907751447,0.03571428571428571,0.13983045389628562,1.0,13/47,24.91%,PAK2;ACTG1;TEAD1;PAK1;LIMD1;CTNNB1;ACTB;MAPK8;NF2;STK3;SAV1;ITGB4;CTNNA1
prerank,Histone Modifications WP2369,0.3583303973057634,1.3666180917600184,0.09523809523809523,0.13891051669959953,1.0,12/67,19.04%,EHMT1;DOT1L;SET;KMT2B;KMT2D;ASH1L;SETD2;KMT5A;H3F3B;SETD5;SETD7;KMT5B
prerank,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.4128758881538298,1.3591643101363198,0.1111111111111111,0.14339253707022975,1.0,8/27,16.27%,MTOR;MAPK1;MAPK3;RPS6KB1;PRKCA;AKT1;RPS6;PRKACA
prerank,Retinoblastoma gene in cancer WP2446,-0.30023813109760306,-1.3576081917282685,0.0851063829787234,0.2521641445846825,1.0,38/87,26.23%,CCNE1;MCM6;PCNA;ORC1;CDC25A;KIF4A;E2F1;RRM1;POLE;CCND3;MCM3;DNMT1;CDK1;RFC5;PRIM1;E2F3;CDC45;POLE2;SUV39H1;CHEK1;POLD3;CCNB1;SMC2;ZNF655;CDC7;POLA1;MSH6;CCNA2;SAP30;FAF1;CCNB2;SMC1A;RFC3;TTK;RFC4;TOP2A;PLK4;MCM7
prerank,Type 2 papillary renal cell carcinoma WP4241,0.37926077365681515,1.3547551461911966,0.08620689655172414,0.14579562006920996,1.0,9/34,22.22%,SFPQ;SLC2A1;VEGFA;DIAPH1;SETD2;ELOB;CUL2;EP300;CDKN1A
prerank,Nuclear Receptors Meta-Pathway WP2882,0.2610408358960286,1.3506125017324173,0.034482758620689655,0.14877000325109271,1.0,47/319,21.49%,MGST1;SLC2A8;RXRA;GPX2;SERTAD2;SLC2A1;ACAA1;PGD;PRDX6;TGFBR2;SP1;ANKRD1;ALDH3A1;CYP1B1;BLVRB;BIRC2;MAFG;UGT1A6;KEAP1;BIRC3;KTN1;ABCC3;NR3C1;BAX;EGFR;SEC14L1;FTH1;GSTM3;SRGN;SLC5A6;GPX3;MYC;ALAS1;PRDX1;SLC39A6;TNFAIP3;SLC7A11;PTGR1;FASN;ARL5B;UGT1A3;GPR153;MFGE8;EP300;CES1;SCNN1A;IL11
prerank,IL-2 signaling pathway WP49,0.3870125421403153,1.35028013200011,0.12727272727272726,0.14811557276341855,1.0,11/42,22.98%,MAPK1;CBL;MAPK3;RPS6KB1;STAT1;AKT1;MYC;RPS6;GRB2;SHC1;SOS1
prerank,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.48066903203860323,1.3464206871548072,0.08620689655172414,0.15073997144700896,1.0,8/44,18.55%,ATF4;CALML5;ITPR3;CREB3L2;CALM2;CALM1;CALM3;CREB3
prerank,mRNA Processing WP411,0.28148538130208306,1.3445129641149662,0.04,0.15126309970284832,1.0,43/126,26.81%,SRSF6;HNRNPA2B1;SRSF10;SFPQ;PABPN1;FUS;CSTF2T;HNRNPU;HNRNPH1;PRMT1;XRN2;RNPS1;SRSF2;DHX15;PRPF3;SRSF5;CELF1;HNRNPL;TMED10;NONO;SRSF3;SF3B1;PCBP2;PTBP1;CSTF3;U2AF2;TRA2B;HNRNPC;CSTF1;SNRPD2;SNRPD3;PRPF40A;CD2BP2;LSM7;SNRNP70;PRMT2;SRSF1;HNRNPD;HNRNPA1;SF3A2;SF3A1;CLP1;CPSF1
prerank,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.44510916460901445,1.3390718078556854,0.15254237288135594,0.15471542428087376,1.0,7/18,14.34%,MTOR;MAPK1;PRKAA1;MAPK3;MKNK2;AKT1;MKNK1
prerank,IL-7 signaling pathway WP205,0.43460385311807276,1.3389092803226441,0.09615384615384616,0.15374845287911829,1.0,8/25,24.81%,MAPK1;MAPK3;STAT1;GSK3B;AKT1;MYC;BAD;CCND1
prerank,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.3677455913828332,1.334336225397143,0.13725490196078433,0.1570458108853613,1.0,13/42,19.87%,MAPK1;TNFRSF12A;MAPK3;BIRC2;GSK3B;AKT1;BIRC3;RAC1;HDAC1;CTNNB1;TRAF2;MAP3K7;MAPK8
prerank,Pathways affected in adenoid cystic carcinoma WP3651,0.3507837806196969,1.3287965854821748,0.1724137931034483,0.16203130695969736,1.0,11/65,16.03%,TP53;SETD2;MORF4L1;ATRX;ARID1A;NCOR1;AKT1;CTBP1;MYC;TLK1;PIK3CA
prerank,NRF2-ARE regulation WP4357,0.46203055378814306,1.327034705132928,0.1702127659574468,0.16256457410469474,1.0,11/23,24.13%,GSK3B;PRKCA;KEAP1;EPHB2;YES1;PIK3CA;SLC7A11;CUL3;MAPK8;NQO1;PGAM5
prerank,IL-18 signaling pathway WP4754,0.2779822708738227,1.3184029540337265,0.034482758620689655,0.16878388033010996,1.0,34/272,18.01%,RANGAP1;BSG;VEGFA;TP53;KIFC3;CLDN1;MAPK1;PIGT;SP1;PLCG1;PRKAA1;SPP1;TRPM7;MAPK3;RPS6KB1;B2M;GSK3B;PRKCA;ITM2C;GPAT4;BIRC3;RPTOR;UGGT1;DEK;BAX;CCDC9;TNFRSF1A;CTNNB1;RPS11;TNFAIP3;HSPB1;STMN1;NACA;ENO1
prerank,Interleukin-11 Signaling Pathway WP2332,0.35810165810546557,1.3179944859892925,0.12962962962962962,0.16804384982613307,1.0,12/44,21.49%,MAPK1;TYK2;MAPK3;RPS6KB1;STAT1;AKT1;IL6ST;YES1;RPS6;PIAS1;GRB2;IL11
prerank,Nanoparticle-mediated activation of receptor signaling WP2643,0.37764557885437866,1.3132456956130714,0.13043478260869565,0.17153070347045044,1.0,12/28,26.59%,AKT3;MAPK1;EGFR;KRAS;NRAS;GRB2;PXN;MAPK8;SOS1;FN1;MAPK11;PTK2
prerank,Prader-Willi and Angelman Syndrome WP3998,0.42114881809654503,1.3129281021380432,0.15384615384615385,0.1708762589161278,1.0,9/61,25.94%,CDK6;TP53;CYFIP1;RB1;PRKCZ;CDKN2A;MKRN3;CCND1;HERC2
prerank,16p11.2 distal deletion syndrome WP4950,0.42535841043847905,1.3112766424342883,0.12280701754385964,0.1711557729710615,1.0,8/31,25.89%,ATXN2L;PRMT1;NFATC2IP;C3;GRB2;TRAF2;RABEP2;TUFM
prerank,Development of ureteric collection system WP5053,-0.39731951095433904,-1.3106878345971187,0.1875,0.3133813520121589,1.0,5/47,14.85%,GRIP1;RARG;GATA3;VANGL2;GLI2
prerank,Oxidative phosphorylation WP623,0.3068650092266507,1.3098075719649096,0.031746031746031744,0.1720764602920462,1.0,16/60,26.62%,ATP5PD;NDUFB7;ATP5MF;NDUFA4;NDUFC2;NDUFB2;NDUFS5;ATP5PB;NDUFS2;ATP6AP1;NDUFA5;NDUFC1;NDUFB6;NDUFA10;ATP5F1B;ATP5MG
prerank,Aryl Hydrocarbon Receptor Pathway WP2873,0.36658672392328545,1.3095004331332314,0.11320754716981132,0.17152188157634718,1.0,11/46,26.48%,MGST1;ALDH3A1;CYP1B1;UGT1A6;BAX;EGFR;UGT1A3;EP300;NQO1;HSP90AA1;JUND
prerank,Fluoropyrimidine Activity WP1601,-0.3459828963024063,-1.30438034746409,0.12903225806451613,0.3070678082903022,1.0,10/33,20.94%,SMUG1;RRM1;ABCC4;ERCC2;CES2;PPAT;XRCC3;UMPS;DPYD;UCK2
prerank,Prostaglandin Synthesis and Regulation WP98,0.3724046733334664,1.3024469955520264,0.14893617021276595,0.17688826297487692,1.0,8/45,18.26%,ANXA1;S100A10;ANXA2;AKR1B1;AKR1C2;AKR1C1;AKR1C3;S100A6
prerank,Autophagy WP4923,0.36941547655534834,1.2957003692734135,0.17543859649122806,0.183187336293023,1.0,8/30,11.82%,AKT1S1;MTOR;PRKAA1;PIK3C3;RPTOR;PRKAB1;ATG5;BECN1
prerank,Notch Signaling Pathway Netpath WP61,0.3200569221889167,1.2682161246568329,0.09615384615384616,0.20982996234444898,1.0,16/61,25.42%,NCOR2;NOTCH2;SKP1;HDAC2;SPEN;GSK3B;NCOR1;AKT1;HDAC1;MYC;EP300;CDKN1A;ITCH;NUMBL;CCND1;RBPJ
prerank,Integrin-mediated Cell Adhesion WP185,0.3126592293811546,1.267505527860322,0.10869565217391304,0.20916058149389383,1.0,28/101,27.11%,ITGA3;VCL;PAK2;AKT3;SHC3;CAPN1;ROCK1;CAPNS1;MAPK1;CDC42;PAK1;AKT1;RAP1B;RAC1;RAP1A;MAPK6;GRB2;PXN;CAV1;CRK;SHC1;SOS1;AKT2;CAPN2;ITGB4;ROCK2;PTK2;PDPK1
prerank,Glucocorticoid Receptor Pathway WP2880,0.32016756937708757,1.2564989920092888,0.11764705882352941,0.22005742239136475,1.0,15/70,21.49%,RXRA;SERTAD2;ANKRD1;BIRC2;BIRC3;KTN1;NR3C1;SEC14L1;SRGN;TNFAIP3;ARL5B;GPR153;MFGE8;SCNN1A;IL11
prerank,Metapathway biotransformation Phase I and II WP702,0.3078173946549948,1.256494835432086,0.125,0.21880709612777743,1.0,19/183,25.53%,MGST1;GPX2;CYP1B1;HS2ST1;UGT1A6;AKR1B1;AKR1C2;AKR1C1;GSTM3;AKR1B10;GPX3;AKR1C3;UGT1A3;CHST11;HS6ST1;NDST1;CHST12;SULT1A1;NDST2
prerank,Adipogenesis WP236,0.2905607340441212,1.252376279280722,0.0967741935483871,0.22310906615334053,1.0,18/130,15.54%,NCOR2;SMAD3;LMNA;RXRA;CFD;SP1;STAT1;CELF1;RB1;NCOR1;LPIN2;BSCL2;GATA2;NR3C1;KLF6;IL6ST;CTNNB1;NAMPT
prerank,p38 MAPK Signaling Pathway WP400,0.3479012852621734,1.2488421207859453,0.12727272727272726,0.2260514958647421,1.0,13/34,21.95%,MAP3K1;CDC42;STAT1;RAC1;MKNK1;HMGN1;MYC;HSPB1;MAP2K4;GRB2;TRAF2;MAP3K7;SHC1
prerank,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.3934956620532893,1.247196744601672,0.16393442622950818,0.22635329244116004,1.0,5/24,8.93%,SLC2A1;TP53;SIRT1;PRKAA1;RB1
prerank,Apoptosis Modulation and Signaling WP1772,0.2840108354748576,1.2437125064361652,0.14583333333333334,0.2295043319384688,1.0,14/90,15.57%,MCL1;TP53;CAPNS1;DFFA;BOK;MAPK3;BIRC2;PMAIP1;BCL2L2;BIRC3;BAX;CDKN2A;TNFRSF1A;BIK
prerank,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,-0.39645314840034507,-1.2373124120720775,0.18604651162790697,0.4158671897058206,1.0,8/15,29.90%,BUB1B;ESPL1;PTTG1;MAD2L1;SMC1A;CENPE;BUB1;SMC3
prerank,Constitutive Androstane Receptor Pathway WP2875,0.42733611680347233,1.2267643806771464,0.2,0.24929771050531307,1.0,8/32,26.47%,RXRA;SP1;UGT1A6;ABCC3;ALAS1;UGT1A3;SULT1A1;HSP90AA1
prerank,Tryptophan metabolism WP465,0.4181856923413141,1.2244205570191034,0.14583333333333334,0.2506636994761,1.0,5/42,7.90%,PRMT1;OGDH;DHCR24;CYP1B1;ALDH3A2
prerank,B Cell Receptor Signaling Pathway WP23,0.29001298488822963,1.2215915345864308,0.1346153846153846,0.25286501183106647,1.0,24/97,27.56%,CARD11;MAPK1;CBL;PLCG1;CDC42;GSK3B;AKT1;RAC1;LYN;MYC;NCK1;GRB2;GTF2I;MAP3K7;MAPK8;CRK;SHC1;SOS1;IKBKG;RPS6KA1;CRKL;PDPK1;PTPN18;BCL10
prerank,T-cell receptor (TCR) signaling pathway WP69,0.3125734954019838,1.2095628966094054,0.17391304347826086,0.26628929302661686,1.0,20/90,27.56%,CARD11;MAPK1;CBL;PLCG1;MAPK3;CDC42;PAK1;AKT1;NCK1;RIPK2;GRB2;MAP3K7;MAPK8;CRK;SHC1;SOS1;IKBKG;CRKL;PDPK1;BCL10
prerank,Oxidative Damage WP3941,0.3940074258676682,1.208592103352374,0.22641509433962265,0.2661114819068494,1.0,9/40,25.67%,MAP3K1;CDC42;TNK2;MAP2K4;TRAF2;C1S;BAD;CDKN1A;GADD45A
prerank,IL-4 signaling pathway WP395,0.3170954150643449,1.207072383090072,0.2037037037037037,0.26677212121442573,1.0,14/54,22.98%,FLNA;MAPK1;CBL;TYK2;MAPK3;RPS6KB1;STAT1;AKT1;PIK3CA;GRB2;EP300;BAD;SHC1;SOS1
prerank,Amino Acid metabolism WP3925,0.2766085231931446,1.1977253934600602,0.1702127659574468,0.27990667004115255,1.0,21/91,23.60%,CPS1;CBS;PYCR1;ACAA1;MCCC1;OGDH;DLD;ACO2;SDHA;BCAT1;ASS1;HIBADH;ODC1;PKM;P4HA2;ACLY;HMGCL;GLUD1;MDH2;CS;DLST
prerank,Trans-sulfuration and one-carbon metabolism WP2525,-0.3627914927212361,-1.1942085937879938,0.1956521739130435,0.4932611999689708,1.0,6/31,14.17%,SHMT1;GSS;PSAT1;MTHFD1L;DNMT1;MTHFD1
prerank,Allograft Rejection WP2328,0.3528899467062523,1.1920374942499687,0.16666666666666666,0.28528720958957876,1.0,8/89,18.77%,VEGFA;CSNK2A2;STAT1;GABPA;PRKCZ;CD55;HLA-DQB1;C3
prerank,Heart Development WP1591,0.3954055568538512,1.1918629447873035,0.23333333333333334,0.28386007946330927,1.0,6/44,19.41%,VEGFA;MAPK1;ERBB3;CTNNB1;NKX2-5;VEGFC
prerank,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.33664403461209363,1.1803860249121156,0.25,0.29677919676896014,1.0,9/66,20.26%,SMAD3;BSG;HDAC2;STAT1;IRF3;TANK;IFNAR1;TRAF2;EP300
prerank,Complement and Coagulation Cascades WP558,0.37394672341923246,1.1721742161467936,0.2549019607843137,0.30736350852918365,1.0,7/58,19.84%,CFD;F3;CD55;CLTC;CLU;C3;C1S
prerank,Nanoparticle triggered autophagic cell death WP2509,-0.3912458944494458,-1.1713225098388722,0.25,0.5312479349765413,1.0,5/23,13.48%,AMBRA1;ATG4A;ATG3;CHAF1A;ATG9B
prerank,CAMKK2  Pathway WP4874,0.34636313649549794,1.1666627897127653,0.19230769230769232,0.3144339011021394,1.0,9/34,16.65%,MTOR;MAPK1;SIRT1;WFS1;MAPK3;RPTOR;RAC1;CALM2;CALM1
prerank,Splicing factor NOVA regulated synaptic proteins WP4148,0.3825422441770553,1.1609434678104344,0.2558139534883721,0.320221728799367,1.0,5/42,13.48%,AGRN;CLSTN1;ATP2B1;PRKCZ;RAP1GAP
prerank,22q11.2 copy number variation syndrome WP4657,0.27440528572787365,1.158141350142166,0.1346153846153846,0.3229021283887036,1.0,14/131,13.91%,RANGAP1;TP53;TNPO1;CLDN1;SLC25A1;EMC10;XPO1;CDC42;DGCR2;CBX5;NCOR1;DGCR6L;EGFR;HIRA
prerank,Signal Transduction of S1P Receptor WP26,0.3749035007806524,1.1578454677863057,0.20833333333333334,0.32148559874144833,1.0,5/25,10.46%,AKT3;MAPK1;MAPK3;AKT1;GNAI2
prerank,Mitochondrial complex I assembly model OXPHOS system WP4324,0.2883405090745984,1.1570309475499672,0.2,0.3211155388070239,1.0,16/56,25.02%,NDUFB7;NDUFC2;TIMMDC1;COA1;NDUFB2;TMEM126B;NDUFS5;TMEM186;NDUFS2;DMAC1;NDUFA5;NDUFC1;NDUFA1;NDUFB6;NDUFA13;NDUFA10
prerank,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.30728069183742107,1.1541748112597605,0.25,0.3228817719915548,1.0,15/55,25.35%,SMAD3;LMNA;NAP1L1;FNTA;SPP1;GSK3B;RB1;HDAC1;CTNNB1;ACTB;CSNK1A1;SMAD2;CDKN1A;AGO2;ZMPSTE24
prerank,Ferroptosis WP4313,0.29751280882162656,1.1513696045730584,0.2553191489361702,0.32628042671067364,1.0,11/40,22.13%,TP53;ACSL1;ATG5;FTH1;PCBP2;ACSL4;NCOA4;SLC7A11;VDAC2;SAT2;FTL
prerank,ATM Signaling Network in Development and Disease  WP3878,0.31055797421353737,1.1494361261733697,0.21568627450980393,0.3274556314311583,1.0,14/45,18.84%,PPP5C;MTOR;PRKAA1;AURKB;RNF40;CDK5;NBN;ATMIN;HMGN1;HSPB1;TRIM28;ATR;RNF20;RAD50
prerank,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.28334891414995833,1.1489490417182788,0.24561403508771928,0.32651853598161135,1.0,22/84,27.11%,MTOR;ROCK1;MAPK1;MAPK3;GSK3B;AKT1;RAC1;CALM2;IL6ST;PIK3CB;CTNNB1;PIK3CA;CALM1;MAP2K4;MAPK8;IGF1R;DVL1;AKT2;PIK3R3;ROCK2;IKBKG;PDPK1
prerank,Vitamin D Receptor Pathway WP2877,0.26591469209548424,1.1487445846290871,0.23076923076923078,0.32528112077087307,1.0,21/182,20.82%,CLPTM1L;RXRA;CBS;CDK2;S100A2;SPP1;LPGAT1;KRT13;KLK6;ATP2B1;TPM1;SLC37A2;CDKN2A;MYC;TNFAIP3;CREG2;IGFBP3;S100A6;MED9;S100A4;TRAK1
prerank,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.397504636304954,1.141835866567725,0.2653061224489796,0.33514796048473827,1.0,5/20,16.64%,ELK4;MAPK1;MAPK3;KRAS;NRAS
prerank,Exercise-induced Circadian Regulation WP410,0.2892861028588451,1.1385585026151828,0.20454545454545456,0.3378659414493681,1.0,11/48,16.61%,QKI;ZFR;EIF4G2;NCKAP1;CRY1;GSTM3;TAB2;NCOA4;SUMO1;VAPA;UGP2
prerank,Rett syndrome causing genes WP4312,0.3438772968820732,1.1367655806700498,0.2830188679245283,0.3388030051414684,1.0,6/48,10.80%,NCOR2;MECP2;HTT;NCOR1;CHD4;HDAC1
prerank,Copper homeostasis WP3286,0.2978843450994563,1.1281857886283384,0.24074074074074073,0.3505088069092514,1.0,11/52,16.58%,TP53;ADAM10;SP1;APP;GSK3B;MT1E;AKT1;XAF1;PIK3CA;ATOX1;MTF1
prerank,Amyotrophic lateral sclerosis (ALS) WP2447,-0.32290310219466956,-1.1247084193443129,0.2708333333333333,0.6296253221436596,1.0,4/38,3.50%,PPP3CB;DAXX;CAT;NEFH
prerank,3q29 copy number variation syndrome WP4906,0.30825184406977374,1.123785968883908,0.25862068965517243,0.35507647340554277,1.0,14/63,23.53%,PAK2;MELTF;ADAM10;DYNLL2;SIRT1;DLG1;AKT1;SENP5;MYC;PXN;NF2;DYNLT1;MCRS1;PIK3R3
prerank,PPAR signaling pathway WP3942,-0.32641314976022373,-1.1167283562426462,0.3191489361702128,0.6284431883453888,1.0,11/67,24.06%,CPT2;PPARD;EHHADH;NR1H3;FABP5;PPARG;SCP2;SLC27A4;SLC27A1;ACSL5;ACOX3
prerank,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.33573958264709725,1.1146034288472662,0.3076923076923077,0.367642901010743,1.0,7/18,23.60%,OGDH;DLD;ACO2;SDHA;MDH2;CS;DLST
prerank,Lung fibrosis WP3624,0.33781608166203125,1.1117465833603213,0.29411764705882354,0.3698400968395664,1.0,4/63,5.43%,MECP2;DSP;ATP11A;SPP1
prerank,Pre-implantation embryo WP3527,-0.3170763448888213,-1.1053897867746727,0.3333333333333333,0.6322312532581481,1.0,7/58,21.38%,PBX1;FOXQ1;AQP3;GATA3;FOXD1;HNRNPAB;BARX2
prerank,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.2629918552422788,1.0966210892259023,0.26666666666666666,0.39077714324710816,1.0,14/69,17.40%,SAR1A;MTOR;SIRT1;SP1;PRKAA1;LSS;NFYA;SCARB1;AKT1;PRKAB1;SEC24C;PIK3CA;PRKACA;FASN
prerank,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.3446073458254729,1.0950397581898497,0.25925925925925924,0.39143547558706393,1.0,7/41,26.68%,AAMP;SUGT1;RAC1;RIPK2;NDUFA13;HSP90AA1;IKBKG
prerank,Male infertility WP4673,-0.2579786273181944,-1.0911343788239147,0.2826086956521739,0.6465104643588752,1.0,24/146,34.09%,TRIP13;CAT;SHMT1;ETV5;XRCC2;MTRR;PSAT1;ERCC2;MTHFD1;AHRR;PARP1;POLB;XRCC3;TCN2;CREBBP;PEMT;DDX20;ABLIM1;PACRG;XPC;SIRPA;HMGA1;MLH1;CDK9
prerank,White fat cell differentiation WP4149,-0.3335801799569631,-1.0758653464242585,0.3137254901960784,0.665779513600102,1.0,4/32,8.82%,CREB1;NR1H3;PPARG;GATA3
prerank,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.26428801204276686,1.0723085251014137,0.3508771929824561,0.4277050767911058,1.0,17/94,21.77%,CDK6;CSNK1E;HNRNPU;DVL3;PORCN;CSNK2A2;GSK3B;TCF3;CTNNB1;CTBP1;MYC;CSNK1A1;MAP3K7;RYK;DVL1;CTNNBIP1;CSNK2A1
prerank,Transcription co-factors SKI and SKIL protein partners WP4533,0.33550384184559456,1.0679631136629097,0.39622641509433965,0.4317793363588142,1.0,9/18,30.51%,MECP2;SKI;TEAD1;HDAC1;STK3;LATS2;SIN3A;SKIL;NF1
prerank,Proximal tubule transport WP4917,0.3284546897857761,1.0655321587516857,0.41304347826086957,0.4338429943129041,1.0,5/57,13.75%,SLC2A1;ATP6V0C;SLC4A2;ATP6V1F;CA2
prerank,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.2873984414787873,1.0651345115658797,0.3469387755102041,0.4323973584787182,1.0,11/49,19.87%,MAPK1;MAPK3;MAP3K1;MKNK2;TANK;MKNK1;TAB2;MYC;MAP2K4;MAP3K7;MAPK8
prerank,IL-1 signaling pathway WP195,0.2970421082638503,1.064815364253605,0.3829787234042553,0.430892800114038,1.0,15/55,28.14%,MAP3K2;MAPK1;PLCG1;MAPK3;MAP3K1;AKT1;PRKCZ;TAB2;MAP2K4;MAP3K7;MAPK8;SQSTM1;TAB3;IKBKG;UBE2V1
prerank,IL17 signaling pathway WP2112,0.3514863371144914,1.0626910944121466,0.32,0.43322004151850324,1.0,7/32,19.56%,MAPK1;SP1;MAPK3;GSK3B;AKT1;PIK3CA;MAP3K7
prerank,Vitamin D in inflammatory diseases WP4482,0.351741753291931,1.0624251436609624,0.3877551020408163,0.4321557786747329,1.0,4/22,12.23%,SMAD3;RXRA;MAP3K1;NR3C1
prerank,Toll-like Receptor Signaling Pathway WP75,0.27846819076760304,1.057034785117392,0.3404255319148936,0.4388097131885262,1.0,20/103,26.68%,AKT3;MAPK1;SPP1;MAPK3;STAT1;AKT1;RAC1;IRF3;TAB2;PIK3CB;PIK3CA;MAP2K4;IFNAR1;MAP3K7;MAPK8;AKT2;PIK3R3;MAPK11;TAB3;IKBKG
prerank,Phosphoinositides metabolism WP4971,0.2868055789790537,1.0519285425186269,0.29411764705882354,0.4446923964407944,1.0,7/49,16.03%,PIK3C2A;PLCG1;MTMR4;PIK3C3;SBF1;PIK3CB;PIK3CA
prerank,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.29140404323150043,1.0454953041349972,0.3018867924528302,0.45313844521718627,1.0,5/74,3.77%,ITGA3;LMNA;DSP;ACTG1;ACTN4
prerank,Wnt signaling WP428,0.24087142376632328,1.0453600936302077,0.3770491803278688,0.45144007251766605,1.0,22/115,25.16%,CSNK1E;DVL3;PORCN;CSNK2A2;GSK3B;PRKCA;RAC1;PRKCG;CTNNB1;CTBP1;MYC;CSNK1A1;DAAM1;MAP3K7;MAPK8;RYK;DVL1;CTNNBIP1;CSNK2A1;CCND1;NLK;ROCK2
prerank,Glycolysis and Gluconeogenesis WP534,0.2741804139108847,1.042612875369123,0.3333333333333333,0.45501362740709705,1.0,8/45,18.01%,GPI;SLC2A1;PFKP;DLD;HK1;ALDOA;PKM;ENO1
prerank,Ciliary landscape WP4352,0.20674404669603216,1.0270003737165148,0.3684210526315789,0.47997576937135417,1.0,43/216,22.94%,VAPB;MKLN1;CBS;HDAC2;DOCK5;DYNLL2;WNK1;RHBDD2;RBM14;DCAF7;DVL3;DYNC1H1;SMC4;CNOT9;RB1;PAFAH1B1;DDX5;CNOT1;RAC1;HDAC1;AIMP1;WEE1;CALM2;MAEA;CTNNB1;COPS2;NEK7;CALM1;RAB21;GDI1;DYNC1I2;YAP1;AGPAT2;DYNLT1;CD2BP2;IFT74;UBE2H;EHBP1;NDUFA5;EXOC8;RABEP2;EXOC5;IFT27
prerank,PPAR-alpha pathway WP2878,-0.34220913958078547,-1.0220041517096625,0.4375,0.7892288376395956,1.0,5/26,12.20%,CPT2;EHHADH;NR1H3;SCP2;CDK1
prerank,1q21.1 copy number variation syndrome WP4905,0.32621071734108253,1.020751919972822,0.509090909090909,0.4900584327560222,1.0,7/27,18.87%,PRKAA1;KIRREL1;PYGO2;PRKAB1;CTNNB1;TJP2;AFDN
prerank,Ethanol effects on histone modifications WP3996,-0.3407050753898936,-1.017586613370379,0.4915254237288136,0.7759201744531817,1.0,6/31,18.70%,HDAC4;SLC19A1;ELP3;HAT1;ATF2;HDAC10
prerank,Purine metabolism and related disorders WP4224,-0.3112074776076988,-1.0087912231119605,0.3902439024390244,0.7766264124760458,1.0,11/22,38.29%,PNP;DGUOK;PPAT;PAICS;PRPS1;ADSS;ITPA;MAT2A;TPMT;HPRT1;ADSL
prerank,DNA IR-double strand breaks and cellular response via ATM WP3959,-0.26419238819811053,-1.007720546699763,0.4423076923076923,0.7561740446826021,1.0,19/55,26.54%,PCNA;RAD51;E2F1;MDC1;RAD9A;DCLRE1C;KAT5;FANCD2;CHEK1;PARP1;RNF8;ATF2;RAD52;BRCA1;UPF1;SMC1A;EXO1;CDC25C;NABP2
prerank,Oxysterols derived from cholesterol WP4545,0.33250872819285016,1.004328561831248,0.42105263157894735,0.5187230113357302,1.0,4/46,11.44%,DBP;ACOT13;THEM5;DHCR7
prerank,Intraflagellar transport proteins binding to dynein WP4532,-0.3348994200463739,-1.0024644439641024,0.4666666666666667,0.747227523798788,1.0,4/27,8.41%,IFT122;WDR34;IFT46;IFT22
prerank,Nuclear receptors WP170,-0.34357335369156256,-1.0017549463141049,0.4222222222222222,0.7282457448716617,1.0,6/38,20.27%,PPARD;RARG;NR1H3;PPARG;VDR;NR0B1
prerank,The influence of laminopathies on Wnt signaling WP4844,0.30406879554258825,0.9930332236236982,0.46153846153846156,0.536875590357336,1.0,5/35,8.73%,CDK6;LMNA;FNTA;SPP1;GSK3B
prerank,Folate Metabolism WP176,0.27457583930721224,0.9907847509707852,0.48148148148148145,0.5397884309760149,1.0,8/69,15.40%,CBS;GPX2;TP53;SCARB1;CSF1;RFK;SAA2;GPX3
prerank,Energy Metabolism WP1541,0.27871286923803473,0.9840495944468101,0.3275862068965517,0.5493636253656479,1.0,9/47,15.04%,RXRA;PRMT1;SIRT1;PRKAA1;GSK3B;PRKAB1;HDAC1;GABPA;MED1
prerank,Type II interferon signaling (IFNG) WP619,-0.3143212328754875,-0.9823820199002012,0.4883720930232558,0.7539483248529704,1.0,9/37,30.51%,HIST2H4A;GBP1;PRKCD;IFI6;JAK2;STAT2;IFNGR2;IRF1;IRF2
prerank,MAPK Cascade WP422,-0.27201708675487807,-0.9661592232463498,0.5681818181818182,0.7775489756590662,1.0,10/33,19.74%,RRAS;ARAF;MAPK12;MAP2K1;MAP2K3;MAP2;ELK1;PLCB3;SOS2;JUN
prerank,Mesodermal commitment pathway WP2857,-0.20874699545730702,-0.9503442485465067,0.5121951219512195,0.8023855150994516,1.0,14/147,12.69%,TCF4;RARG;PBX1;HMGA2;GRHL2;TRIM5;CSRP2;AEBP2;JARID2;GATA3;C1QBP;ZNF281;NOG;RGS10
prerank,Unfolded protein response WP4925,0.2847322992862651,0.9302153798815271,0.6,0.657037048285099,1.0,3/24,8.57%,ATF4;TP53;PMAIP1
prerank,Prion disease pathway WP3995,0.28893851938315174,0.9292461601953311,0.5106382978723404,0.656142230057836,1.0,8/33,26.59%,RXRA;MAPK1;MAPK3;BATF;HSP90B1;EP300;CTCF;PTK2
prerank,Joubert Syndrome WP4656,0.24724204179834058,0.9291430198292615,0.5892857142857143,0.6537059333664509,1.0,11/76,24.23%,ATF4;FLNA;MTOR;DVL3;ARL13B;CETN2;RAD50;PDE6D;DVL1;RHEB;ANKS6
prerank,Cell cycle WP179,0.20210045318240671,0.9230258545943789,0.55,0.6634298221903371,1.0,32/120,25.78%,CDK6;SMAD3;STAG2;CDC25B;TP53;CDK2;FZR1;SKP1;YWHAZ;HDAC2;YWHAG;GSK3B;RB1;HDAC1;ORC4;WEE1;CDKN2A;ANAPC13;MYC;YWHAB;ATR;YWHAE;EP300;SMAD2;CDKN1A;CDC16;SFN;ANAPC1;MAD1L1;CCND1;GADD45A;ANAPC2
prerank,Metabolic reprogramming in colon cancer WP4290,0.22857089606886247,0.9169725350468668,0.5901639344262295,0.6722021110911841,1.0,13/42,23.60%,GPI;PYCR1;SLC2A1;PGD;ACO2;PKM;FASN;ENO1;PDHB;ACLY;GLUD1;MDH2;DLST
prerank,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.2873080935013485,0.9084799335365566,0.5740740740740741,0.6856869972329394,1.0,7/32,24.81%,TPM3;NR3C1;EGFR;ERBB3;MYC;CAV1;CCND1
prerank,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.24227608693587674,0.9029101736572503,0.6,0.6944885503649764,1.0,8/46,17.40%,DHCR24;MYLIP;LSS;ACSL1;DHCR7;SC5D;ACSL4;FASN
prerank,TYROBP causal network in microglia WP3945,0.25250053044020343,0.8974840100140464,0.6545454545454545,0.7020946942869158,1.0,8/61,23.28%,SFT2D2;CAPG;SPP1;CREB3L2;TCIRG1;C3;NPC2;ZFP36L2
prerank,Sphingolipid Metabolism (general overview) WP4725,-0.3142455619366171,-0.8947963451127557,0.6304347826086957,0.918857921302909,1.0,5/24,16.70%,PLPP3;SGPL1;SGMS2;SPHK1;SMPD1
prerank,Sphingolipid Metabolism (integrated pathway) WP4726,-0.299503251698996,-0.8834508852613709,0.6086956521739131,0.9295975682283752,1.0,5/25,16.70%,PLPP3;SGPL1;SGMS2;SPHK1;SMPD1
prerank,Selenium Micronutrient Network WP15,-0.22823046111882356,-0.8753134491244763,0.7272727272727273,0.926584285997489,1.0,8/89,9.95%,ALOX5;FLAD1;SELENOM;CAT;SELENOK;LDLR;SEPHS2;PRDX3
prerank,Genotoxicity pathway WP4286,-0.23713604112011125,-0.873159123973385,0.6590909090909091,0.909544892429978,1.0,5/63,10.47%,E2F8;TIGAR;TRIAP1;E2F7;HIST1H2BC
prerank,Gastric Cancer Network 1 WP2361,-0.2516072984835105,-0.8689510549429571,0.6818181818181818,0.8986413490308413,1.0,13/29,40.32%,E2F7;NUP107;RUVBL1;GATD3B;TOP2A;KIF20B;TPX2;AURKA;GATD3A;S100P;MYBL2;H3F3A;HIST4H4
prerank,p53 transcriptional gene network WP4963,0.2252165872718637,0.8675112085554427,0.7,0.7586133320600749,1.0,8/67,16.53%,SLC2A1;THBS1;PMAIP1;PRKAB1;BAX;FUCA1;CCNG1;SLC7A11
prerank,Differentiation Pathway WP2848,0.28821740513009286,0.8617708876850547,0.6428571428571429,0.7682396822700319,1.0,6/48,33.15%,VEGFA;CSF1;IL11;INHBA;NT5E;PDGFB
prerank,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,-0.248767566990297,-0.8587095385667833,0.6111111111111112,0.9040702738746749,1.0,8/36,20.04%,MAPK12;JUNB;MAP2K1;MAP2K3;ATF2;MAP3K11;JUN;EIF4E
prerank,Urea cycle and associated pathways WP4595,0.2820584575219048,0.8489896478611687,0.6136363636363636,0.7882019563943101,1.0,3/24,10.09%,CPS1;PYCR1;ASS1
prerank,miRNAs involvement in the immune response in sepsis WP4329,0.2623692980921536,0.8487521830707833,0.72,0.7856309306300466,1.0,6/37,26.82%,TAB2;MAP3K7;MAPK8;NFKB2;IKBKG;LCN2
prerank,Immune response to tuberculosis WP4197,0.30711074485319056,0.8471285836499388,0.7254901960784313,0.78527637368805,1.0,5/23,19.36%,TYK2;STAT1;PIAS1;IFNAR1;MED14
prerank,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.2626384538153008,0.8386586394708119,0.7090909090909091,0.798684076576456,1.0,3/21,12.59%,MCL1;AKT1;BAX
prerank,Oxidative Stress WP408,0.2576823335352276,0.8367661871236721,0.7413793103448276,0.7987269405316203,1.0,4/33,15.40%,MGST1;SP1;UGT1A6;GPX3
prerank,ESC Pluripotency Pathways WP3931,0.20431852165090414,0.8342678132205579,0.7413793103448276,0.7999810625640709,1.0,14/116,22.99%,AKT3;MTOR;MAPK1;DVL3;GSK3B;AKT1;EGFR;IL6ST;CTNNB1;MAPK6;GRB2;DVL1;SOS1;AKT2
prerank,Parkinson's disease pathway WP2371,0.25564987866430816,0.8325397993416321,0.7307692307692307,0.7997642482465964,1.0,9/38,26.20%,UCHL1;PARK7;UBB;UBE2J1;UBE2L3;UBE2G1;UBE2J2;UBE2G2;MAPK11
prerank,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.21688091706913465,0.8176990444308596,0.6730769230769231,0.8239638782313444,1.0,14/50,26.47%,MCL1;TP53;RB1;BAX;EGFR;CDKN2A;TNFRSF1A;MAP2K4;TRAF2;MAPK8;CDKN1A;CCND1;MAPK11;HSP90AA1
prerank,Hippo-Yap signaling pathway WP4537,0.25295388437060995,0.8166718511810316,0.8,0.8231477679105118,1.0,6/23,22.97%,TEAD1;NDRG1;NF2;STK3;SAV1;LATS2
prerank,One-carbon metabolism and related pathways WP3940,0.24174456376337655,0.8146537988314481,0.711864406779661,0.8230283833703754,1.0,7/52,18.69%,GPX2;ETNK1;CHKA;BCAT1;AHCYL1;GPX3;DNM1
prerank,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.2516472297056767,0.8106911823146704,0.7818181818181819,0.8257219364876255,1.0,7/33,19.87%,TYK2;EIF2AK2;STAT1;IRF3;IFNAR1;MAP3K7;MAPK8
prerank,DNA damage response WP707,-0.1961020962907707,-0.8052172734662617,0.7297297297297297,0.9984845481178,1.0,14/68,20.23%,CREB1;CCNE1;RAD51;CDC25A;E2F1;CCND3;RAD9A;CDK1;FANCD2;CHEK1;CCNB1;RAD1;RAD52;BRCA1
prerank,Neural Crest Differentiation WP2064,-0.22090708150911212,-0.8004354703069535,0.7454545454545455,0.9848847465515904,1.0,10/101,21.39%,HDAC4;TCF4;ID1;TFAP2A;SNAI2;HES1;HDAC11;RHOB;HDAC10;AXIN1
prerank,Gastric Cancer Network 2 WP2363,0.24576547779075486,0.7995183957512382,0.7272727272727273,0.8393479106500854,1.0,7/31,18.85%,TP53;EGFR;CTNNB1;FAM91A1;MYC;S100A6;BRIX1
prerank,miRNA regulation of DNA damage response WP1530,0.1957213944899942,0.7889951702857965,0.8032786885245902,0.852555358808768,1.0,13/71,18.84%,CDK6;TP53;CDK2;PMAIP1;RB1;CDK5;NBN;BAX;CCNG1;MYC;TLK1;ATR;RAD50
prerank,Glycosylation and related congenital defects WP4521,-0.2491121618494721,-0.7726569201027734,0.8888888888888888,1.0,1.0,3/25,11.25%,ALG1;DOLK;B4GALT1
prerank,Eukaryotic Transcription Initiation WP405,-0.19883858122664894,-0.7720315582276448,0.9,0.9924998347981233,1.0,5/43,10.06%,GTF2H4;POLR1A;POLR3K;ERCC2;TAF6
prerank,Toll-like Receptor Signaling related to MyD88 WP3858,0.2585537832917061,0.7671344300081326,0.7391304347826086,0.8824524918118364,1.0,8/31,40.46%,MAPK1;IRF3;NFKB2;IKBKG;TBK1;TLR6;IRAK1;RELB
prerank,Glycerophospholipid Biosynthetic Pathway WP2533,0.21573923830494374,0.7603418350423691,0.8214285714285714,0.8888046104842904,1.0,5/30,16.03%,LPIN2;GPAT4;AGPS;PIK3CB;PIK3CA
prerank,SARS-CoV-2 mitochondrial interactions WP5038,-0.2403321383098136,-0.7560136552134972,0.6976744186046512,0.9982266084257002,1.0,4/32,22.86%,ACAD9;CGAS;TICAM1;CTSL
prerank,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,-0.22238264599321525,-0.7555408073381593,0.8444444444444444,0.9790907288706799,1.0,2/32,0.90%,PPP3CB;HDAC4
prerank,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.2038521737772077,0.7539768684249398,0.9,0.8932077042559224,1.0,17/60,33.24%,SIKE1;MAP3K1;ATG5;IRF3;TANK;DDX17;TRAF2;MAP3K7;MAPK8;DDX3X;TRIM25;MAPK11;IKBKG;AZI2;ATG12;PIN1;TBK1
prerank,Host-pathogen interaction of human coronaviruses - autophagy WP4863,-0.2777059881352519,-0.7532750034032099,0.7254901960784313,0.9626255048374996,1.0,4/19,12.29%,ZFYVE1;ATG4A;ATG3;WIPI1
prerank,Physiological and pathological hypertrophy of the heart WP1528,0.24030268056473103,0.7514971445216346,0.8076923076923077,0.893121942594448,1.0,6/25,19.87%,MAPK1;RAC1;CALM2;IL6ST;CALM1;MAPK8
prerank,Cytosolic DNA-sensing pathway WP4655,-0.20128623673423396,-0.7509092371276503,0.9130434782608695,0.9473006013348312,1.0,18/75,36.60%,RIPK1;NFKBIB;POLR3GL;POLR3K;NFKBIA;POLR3A;CGAS;CYLD;POLR3F;TRADD;POLR3C;POLR3B;CHUK;IL6;FADD;TREX1;PYCARD;CASP8
prerank,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.19414851858193366,0.7470098694970585,0.8571428571428571,0.8947994636647609,1.0,15/86,25.12%,CSNK1E;DVL3;PORCN;CSNK2A2;GSK3B;CTNNB1;CTBP1;MYC;CSNK1A1;RYK;DVL1;CTNNBIP1;CSNK2A1;CCND1;NLK
prerank,Signal transduction through IL1R WP4496,-0.23186604824841814,-0.7371399082811594,0.7959183673469388,0.9467675915062547,1.0,7/33,32.56%,IL1RN;NFKBIA;MAP2K3;JUN;TOLLIP;CHUK;IL6
prerank,Photodynamic therapy-induced unfolded protein response WP3613,0.21221732468392196,0.7280045638143426,0.8235294117647058,0.9155955976800009,1.0,4/27,15.12%,ATF4;DNAJC3;EIF2A;HSP90B1
prerank,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.21253113573086096,0.7149755677056618,0.9,0.9255559012638761,1.0,8/24,29.34%,KEAP1;ABCC3;MAPK8;CES1;NQO1;MAPK11;ABCG2;GCLM
prerank,Proteasome Degradation WP183,-0.16953535084022284,-0.7084679735158179,0.96,0.960762718708929,1.0,18/62,29.86%,PSMD13;PSMD1;PSMD6;PSMB8;PSMC4;PSMD11;PSMB2;PSMA3;PSMB7;PSMD10;UBE2D2;HLA-E;PSMB1;PSMA1;H2AFX;PSMD3;PSME1;UCHL3
prerank,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.24403931756448727,0.7017039182153875,0.9245283018867925,0.9328560346418542,1.0,6/38,23.53%,ROCK1;PLCG1;PIK3CB;PIK3CA;SHC1;PIK3R3
prerank,Glycerolipids and Glycerophospholipids WP4722,0.2331289185418901,0.6746969472286697,0.84,0.9511712781825353,1.0,3/22,16.08%,ETNK1;GPAT4;DGKZ
prerank,Fatty acid beta-oxidation WP143,-0.19685518690933412,-0.6393458519937821,0.9607843137254902,0.9943146525053614,1.0,7/34,24.31%,CPT2;ACAT1;HADH;DECR1;ECI1;ACSL5;HADHB
prerank,Sphingolipid pathway WP1422,0.20941127297012352,0.6328358859987487,0.9,0.974234636674708,1.0,2/30,3.33%,SPTLC2;PPP1CA
prerank,TLR4 Signaling and Tolerance WP3851,-0.21671801045144984,-0.6312716659968634,0.9074074074074074,0.9818053733090408,1.0,3/28,19.60%,RIPK1;NFKBIA;TICAM1
prerank,Fatty Acid Biosynthesis WP357,0.20385495945374627,0.6240765866652709,0.9433962264150944,0.9749108844874896,1.0,5/22,22.88%,ACSL1;ACSL4;FASN;ACLY;MECR
prerank,Wnt signaling in kidney disease WP4150,0.2154663450263154,0.6122907084630823,0.9491525423728814,0.9759961239901837,1.0,4/36,20.98%,DVL3;CTNNB1;MAPK8;DVL1
prerank,Vitamin B12 metabolism WP1533,0.19184540402549555,0.598185656142505,0.9824561403508771,0.9777214593033535,1.0,4/50,19.40%,CBS;SCARB1;SAA2;SAA1
prerank,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,-0.16356236686137648,-0.5396940150237823,1.0,0.9922024714200753,1.0,8/33,32.90%,MBTPS2;TMEM38B;MBTPS1;COL1A1;PPIB;P4HA1;COLGALT1;PLOD2
